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ABSTRACT 
This project consisted of a two pronged investigation into the role of coping strategies in 
psoriasis - a chronic, relapsing skin condition associated with impoverished quality of life 
and substantial psychological distress. The first study examined the relative influence of 
coping strategies on sufferers' subjective disability and psychological distress. The second 
study explored the efficacy of a pilot group intervention based on the format of Coping 
Effectiveness Training. 
Study one utilised the theory of Appraisal and Coping (Lazarus & Folkman, 1984) to 
investigate the role of coping strategies in mediating sUbjective disability and 
psychological distress in 89 psoriasis sufferers. Empirical definitions of adaptive and 
maladaptive coping strategies were used to categorise coping. Maladaptive coping 
strategies, in particular venting emotions and mental disengagement, were significantly 
associated with both subjective disability and psychological distress, accounting for a 
greater proportion of the variance on these measures than age, gender or duration of 
psoriasis. Adaptive coping strategies were not inversely associated with the outcome 
measures. 
Study two piloted a group based intervention derived from Coping Effectiveness Training 
- a structured problem focused group - with a self selected community sample of 16 
psoriasis sufferers. While the intervention did not yield significant changes on outcome 
measures relative to the control group, there was a trend for a reduction in subjective 
disability. Participant feedback suggested that the intervention was felt to be useful and 
that specific coping techniques had been acquired as a result of the intervention. 
Implications are discussed in terms of the roles of coping strategies and the use of 
structured group interventions in psoriasis, and suggestions for future research are 
outlined. 
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I INTRODUCTION: OVERVIEW 
The aims of this project were to investigate the coping strategies mediating subjective 
disability and psychological distress in psoriasis and to carry out a pilot intervention 
based on Coping Effectiveness Training. 
The project is divided into two studies which were undertaken concurrently and represent 
an investigation into coping in psoriasis which is not known to have been carried out 
before with this population. 
Study one is the systematic investigation of the mediating role of coping strategies in 
subjective disability and psychological distress in psoriasis. Study two is the group based 
intervention. 
The introduction is composed as follows: 
Part 2 - Medical information about psoriasis 
Part 3 - Review of psychological factors in psoriasis and the factors predicting subjective 
disability and psychological distress. 
Part 4 - Outline of theory of stress and coping, and development of Coping Effectiveness 
Training. 
Part 5 - Aims of studies one and two. 
2 PSORIASIS: MEDICAL INFORMATION 
2.1 Epidemiology and prevalence 
Psoriasis is an incurable, chronic, relapsing skin condition affecting 1 % to 3% of the 
population. Men and women are equally affected, with a peak age of onset between 10 
years and 30 years of age (Venables 1994). Psoriasis may occur from birth; up to 10% of 
sufferers develop the condition before the age of 10 years (Roenigk & Maibach, 1985). 
The most frequently affected sites of the body are the scalp, elbow and trunk, although 
any area of the body may be affected. Several morphological types of psoriasis have been 
identified, which vary in clinical presentation and have been linked to different causes. 
The most common form is plaque psoriasis which appears as raised red patches of skin 
covered with silvery scales. The individual lesions may merge together and can cover the 
entire body. Guttate psoriasis has the appearance of a rash and often develops following 
respiratory infections, streptococcal pharyngitis and viral flu. Pustular Palmar-plantar 
psoriasis - painful pustules on palms of hands and soles of feet - often occurs with fever 
and is also associated with withdrawal of steroids. Nail changes are common in psoriasis: 
yellowing and splitting may occur on some or all fingernails. Arthritis is also associated 
with psoriasis in approximately 6% of people with psoriasis and most commonly affects 
the hand joints. While these types of psoriasis are not life threatening, generalised 
pustular psoriasis and erthyrodermic psoriasis are serious illnesses requiring hospital 
admission (Roenigk & Maibach, 1985) . 
The prevalence of psoriasis decreases with age in the population. Within an individual, 
psoriasis may become more widespread throughout the body. Psoriasis typically follows 
a relapsing and remitting course: around 40% of patients experience remission lasting 
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from one to 54 years. In up to 30% of cases, spontaneous remission may occur without 
treatment, the cause of which is unknown (Roenigk & Maibach, 1985). 
2.2 Aetiology 
Psoriasis results from an acceleration of the normal process of skin replacement. A skin 
cell normally matures in 21 to 40 days, reaching the surface layer where a constant 
shedding of dead cells in the form of scales takes place. In psoriatic cells, this process 
occurs in two to three days and cells accumulate in visible layers. No single cause for 
psoriasis has been identified and it is likely that many factors are involved. There is a 
genetic susceptibility - with 35% of sufferers having a family occurrence. Early onset is 
most associated with familial factors. Many other factors such as climate, infections, 
hormonal changes, surgical trauma to the skin, certain drugs such as lithium, and 
psychological stress in the form of negative life events have been linked to an outbreak 
or relapse (Keinan, Segal, Gal, Brenner, 1995; Roenigk & Maibach, 1985). 
2.3 Measures of severity 
Objective measures use dermatologist ratings of psoriasis area and severity at different 
body sites (Roenigk & Maibach, 1985). Patient reported measures of severity, such as 
degree of itch, pain, discomfort, are also used. (McHenry & Doherty, 1992). 
2.4 Medical effects and treatments 
Apart from the disfiguring of the skin, sufferers may also experience extreme discomfort 
or pain, pruritus, and bleeding. Arthritis may cause additional difficulties with joint pain 
and immobility. Side effects from treatments may also be severe. Psoriasis is managed 
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using a combination of topical steroid creams, coal and wood tar derivatives, systemic 
treatments including chemotherapy, and ultra-violet light treatment - which requires 
hospital attendance. 
Coal and wood tar derivatives come in the form of ointments, gels and bath solutions. 
Skin irritation, or acne may result. Corticosteroids are widely used, possible side effects 
including further skin complications such as allergic contact dermatitis. Use of creams 
and ointments are messy and time consuming and often requires several administrations 
over the course of a day. For severe psoriasis, ultra violet phototherapy and / or 
systemically administered medications are used, a common one being the antimetabolic 
drug methotrexate. Side effects may include headaches, fatigue, dizziness, 
gastrointestinal problems, depression and liver disease. Phototherapy, (UVB or PUV A) 
normally requires 20 to 30 treatments, three times weekly (Roenigk & Maibach, 1985) . 
2.5 Summary 
Psoriasis is a chronic, relapsing skin condition affecting 1 % to 3% of the population. 
Severity, course, and age of onset may vary greatly between individuals. Psoriasis itself 
is not curable and can be disabling, painful and itchy. It is managed with a combination 
of topical treatments, and in severe cases with systemic drugs and phototherapy, which 
have potentially severe side effects. In addition, 6% of individuals suffer from psoriatic 
arthritis. There is no single known cause, although a genetic predisposition exists. 
Periods of relapse have been linked, among other factors such as surgical trauma and 
certain medications, to the experience of negative life events. 
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3 IMPACT ON QUALITY OF LIFE 
"Because the disease is rarely fatal, its psychological impact may receive inadequate 
attention; the patient may ultimately feel like a medical nuisance, resistant to cure." 
(Weinstein, 1984, page 513). 
3.1 Psychological aspects of the condition 
Quality of life refers to the overall subjective impact ofa condition on the sufferers 
physical, psychological and social life. Until recently there was a relative lack of 
attention paid to the impact of psoriasis on overall quality of life (McKenna & Stern, 
1997). Early research into psychological aspects of psoriasis were dominated by "futile 
searches for the 'psoriatic personality'" (Weinstein, 1984 page 509), in attempts to 
implicate underlying personality traits, or emotional disturbance, as causative factors in 
the disease onset (Ginsburg & Link, 1993; Weinstein, 1984). Such suggestions seem to 
serve to show the extent of public hostility towards sufferers of the condition, 
highlighting that sufferers not only have psoriasis to deal with, but the attitudes of those 
around them (Ginsburg & Link, 1993). 
More recently, research has focused on two areas; the role of psychological factors, 
particularly stressful events, in exacerbating the condition, and the psychosocial aspects 
of living with psoriasis itself (Weinstein, 1984). 
Several studies have sought to demonstrate a direct link between experience of stressful 
life events and subsequent flare up of psoriasis through retrospective surveys or use of 
diaries (King & Wilson, 1991). While self report methodology leaves findings open to 
s 
question, there has been a consensus from sufferers in a number of surveys endorsing 
stress as a factor in exacerbating their condition. In a community survey, 37% of 
respondents believed that recent stressful events precipitated an acute phase of psoriasis 
(Nevit & Hutchinson, 1996). The immune system has been proposed as a pathway 
through which stress may influence the condition, as has been suggested in HIV (Antoni, 
1997). Thus a feedback loop may be initiated, with psoriasis itself acting as a stressor, 
triggering further flares (Ginsburg & Link, 1993). 
Considering the chronic, unpredictable course of psoriasis, lack of a cure and its visibility 
and associated pain and discomfort, it is not surprising that the impact on quality of life 
may be substantial. Development of psoriasis-specific measures of subj ective disability 
and distress have enabled psychosocial factors to be assessed in greater detail: emotional 
distress, social and occupational functioning, and self concept are the main areas which 
research surveys have addressed. 
3.1.1 Emotional distress 
There have been a number of surveys of both community and inpatient populations 
documenting emotional distress in the form of worry, despair, elevated rates of 
depression and anxiety (Dooley & Finlay, 1990; Ginsburg & Link, 1989; McKenna & 
Stem, 1997), and low overall perception of quality of life (O'Neill & Kelly, 1996). In a 
review, Ginsburg (1995) reported clinical rates of depression in a third of dermatology 
inpatients with psoriasis and in 15% of outpatients with psoriasis when a standard 
measure of depression was used. Most studies are cross sectional which may not take 
account ofthe variability in distress due to psoriasis over time. Fried et al (1995) 
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developed a self report questionnaire to discover the type and degree of psychosocial 
impairment present during acute flares of psoriasis. Nearly half of their sample of 64 
outpatients reported moderate or extreme depression during flares, which is consistent 
with findings relating flare up to despair (Ginsburg & Link, 1989). Fried et aI's study 
also reported significant (45% of respondents) psychological consequences of having the 
diagnosis of psoriasis itself, irrespective of current state of the skin. In the largest 
longitudinal study found in the literature, McKenna & Stem (1997) followed up over one 
thousand patients who had been seen for phototherapy treatment in 1979. Symptoms of 
depression and anxiety were self reported by 22%, and the psychological dimensions 
were reported to be the most affected compared to physical and social. A strong positive 
correlation has also been found between pruritus, depression and anxiety, pruritus being 
independent of severity (Gupta & Gupta et a11994). Elevated rates of suicidal ideation 
have also- been reported relative to the normal popUlation; Gupta & Schork et al (1993) 
found that 10% of a mixed sample of inpatients and outpatients expressed a wish to be 
dead, while 5% admitted to active suicidal plans. In their study, depression was linked to 
self rated psoriasis severity. 
3.1.2 Social and occupational functioning 
There is empirical evidence for substantial social distress and impairment in areas of 
interpersonal relationships, work and social activities. It seems that well established 
relationships may be relatively unaffected and provide a primary source of support (Koo, 
1996) while new relationships are hard to form: 67% of a community sample claimed 
their lives had been adversely affected by psoriasis, including difficulties 
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fonning new social relationships and restriction of activities (McHenry & Doherty, 
1992). Psoriasis may also affect sexual relationships in 30% to 70% of people, both due 
to direct - presence of genital psoriasis - and indirect - depression, social avoidance -
factors (Gupta & Gupta, 1997). 
Psoriasis clearly affects many sufferers ability to work. For half of the patients in 
McKenna & Stern's study (1997), who were not working, the reasons cited for not 
working were psoriasis or psoriatic arthritis. Similarly, Finlay & Coles (1995) found that 
one third of their sample attributed not working to psoriasis, and 60% took over 26 days 
leave during the year for treatment. 
Avoidance of social situations is commonly reported in the literature. Ramsay & 
O'Reagan (1988) and Ginsburg & Link (1989) reported that over two thirds of their 
samples avoided common social activities, such as swimming, sunbathing, playing sports 
and visiting the hairdresser. Of particular concern, 11% to 15% of sufferers have 
admitted to avoiding leaving their own homes altogether, while 11 % believed they would 
avoid having children in case they too developed psoriasis (Fried et aI, 
1995; Ramsay & O'Reagan 1988). These patterns of avoidance were unrelated to 
severity of psoriasis (although the whole sample represented the more severe end of the 
spectrum of sufferers). In the fifteen year follow up study, 14% reported interference in 
nonnal social activities (McKenna & Stem, 1997), the notably lower figure possibly 
relating to the random nature of the follow up - regardless of whether patients were 
currently symptomatic. 
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3.1.3 Self concept 
The visibility ofa skin condition "attacks the very identity of the individual" (Ginsburg 
1995, page 793), being central to that individual's self perception and experience in the 
social world. Embarrassment has been rated by patients as the "worst thing" about 
psoriasis since the early surveys were undertaken (Savin, 1970). In addition to the 
inherent difficulties in living with psoriasis, other opportunities for enhancing self 
esteem, such as work and social activities, may also be restricted, putting the individual 
at increased risk of negative self concept (Ginsburg & Link, 1993). The detrimental effect 
of psoriasis on aspects of self concept is being increasingly recognised and 
operationalised. 
Self concept has been shown to be relatively stable in patients with psoriasis - not 
fluctuating with changes in condition severity: McKenna & Stem (1997) found that 
nearly 40% of the sample in their follow up study did not feel better about themselves 
despite physical improvement after intensive treatment, and they concluded that psoriasis 
has an "unremitting effect on the psyche" (page 393) for many people. So the impact on 
self concept has the potential to endure and persist after physical symptoms have lessened 
Body image has been shown to be adversely affected in psoriasis sufferers in many 
studies; particularly frequently cited in surveys are "feeling unclean", and "physically 
unattractive" (McKenna & Stem 1997). Beliefs in others' negative perceptions were also 
commonly identified in surveys (Ramsay & O'Reagan, 1988) and have now been 
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incorporated into psoriasis-specific measures of stress (Fortune et aI, 1997 a; Gupta & 
Gupta, 1995a) or stigma (Ginsburg & Link, 1993). 
The concept of stigma has been used to measure individuals' experiences of having 
psoriasis: stigma is defined as a biologic or social mark that sets a person off from others 
(Ginsburg and Link, 1989) and thus may leave a person susceptible to experiencing 
shame (Gilbert, 1997) . A wide variability in feelings of stigmatisation were reported 
(Ginsburg & Link, 1993), which were not predicted by extent or visibility of skin 
involvement. Ginsburg and Link (1993) found many examples of gross experiences of 
rejection (such as being asked to leave a public place) and related stigma to anticipation 
of rej ection. 
3.1.4 Summary 
In addition to the distressing, painful and frequently debilitating nature of the symptoms, 
psoriasis has a substantial impact on psychosocial aspects of quality of life and has been 
associated with anxiety, depression, shame, social avoidance, reduced ability to work, 
and relationship and sexual difficulties. This review will now turn to the factors that 
have been found to mediate subjective disability and emotional distress. 
3.2 Factors predicting subjective impact 
Research has consistently shown that the subjective disability and emotional distress an 
individual suffers as a result of psoriasis is not a simple function of objective severity 
(Fortune et aI, 1997a; Ginsburg & Link, 1989; McKenna & Stem, 1997; Root & Kent, 
1994). Patient rated psoriasis severity has been shown to often correlate poorly with 
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doctor rated severity (Root & Kent, 1994), suggesting that what is important in a medical 
sense may not be the most salient or troubling aspect to the sufferer of the condition. 
Research has attempted to ascertain which factors predict psychosocial outcome. 
Variables investigated in the literature can be broadly grouped into: demographic and 
psoriasis-specific variables; beliefs, behaviours and coping strategies. 
3.2.1 Demographic and psoriasis-specific variables 
Early research suggested that women were more likely than men to experience socially 
adverse effects of psoriasis due to the increased importance that society places on 
appearance of women (Gupta & Gupta, 1995b). However, recent surveys using measures 
of psoriasis related stress and self ratings of psoriasis severity (which have been found to 
correlate with measures of quality of life (Koo, 1996; Root & Kent, 1994)} found that 
there were no gender differences in overall impact on socialisation associated with 
psoriasis (Dooley & Finlay, 1990; O'Neill & Kelly, 1996), but that men were more afraid 
oflosing their job (Gupta & Gupta, 1995b). Such different findings may reflect changed 
roles in society , or an increased willingness for men to admit to the difficulties caused by 
psoriasis. Significant differences have, however, been found with age in a number of 
studies; younger people being the most adversely affected by psoriasis (Gupta & Gupta, 
1995b; McKenna & Stem, 1997). These authors attributed age differences to the 
increased importance of social stigma in the under 45 year age group, whereas for 
individuals over 45 years of age social networks are more likely to be established and 
stable. Other recent research supports these findings: Nevitt & Hutchinson (1996) also 
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failed to find gender differences in ratings of concern over the condition, but did find that 
concern was inversely related to age. 
Being in employment has been found to be a buffer to psychological impact (Ginsburg & 
Link, 1993), possibly because of the opportunities it provides for social support and as a 
source of self esteem (Ginsburg & Link, 1993). 
Specific psoriasis dimensions such as itchiness, extent of bleeding, visibility have also 
been investigated independent of overall severity. Perceived stigma was highly predicted 
by extent of bleeding of skin lesions (Ginsburg & Link, 1989) but not by extent or 
visibility of skin condition. Pruritus has been considered in a few studies and seems to 
have a large impact on quality of life and emotional distress: Fried et al (1995) found a 
strong correlation between itching, depression and anxiety. However, from a cross 
sectional design, it is impossible to tell the direction of causality. Gupta & Gupta et al 
(1994) found a strong correlation between depression and pruritus, and hypothesised that 
depression itself lowered the threshold for pruritus perception. 
3.2.2 Beliefs, behaviours and coping strategies 
In general, self rated severity has been found to correlate well with measures of impact on 
quality of life and general physical and mental health (Koo, 1996; Root & Kent, 1994) as 
well as with depression (Gupta & Schork et aI, 1993). Selfrated severity consists of an 
individual's perception of and beliefs about their condition. Scharloo et al (1998) found 
that impact of psoriasis on quality of life was significantly predicted by an individuals 
beliefs about their condition, in particular, a belief that they were suffering 
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from a serious illness which was uncontrollable and long lasting. The authors concluded 
that such beliefs have direct effects on functioning and psychological outcome. However 
this study did not measure psychological distress. Fortune et al (1997b), using a measure 
termed the psoriasis life stress inventory, identified specific beliefs and coping 
behaviours in patients with psoriasis which mediated the effect of the condition on 
subjective disability, being larger predictors than medical measures of severity. These 
were anticipatory-avoidance behaviour and beliefs or experience of others' negative 
evaluations. 
Social support has been found to be a protective factor in psoriasis. Coping by seeking 
social support was significantly correlated with lower subjective disability (Scharloo et 
aI, 1998). However, avoidance of social activities is common in people with psoriasis 
across the range of severity (Ramsay & O'Reagan, 1988). Rejection experiences were 
strongly correlated with perceived stigma, and highly related to despair (Ginsburg, 1995). 
Ginsburg & Link (1993) suggested that despair may influence psoriasis indirectly via 
failure to comply with treatment. Alcohol consumption was also significantly predicted 
by rejection experience and correlated strongly with despair (Ginsburg 1995). 
3.2.3 Summary 
The identification of key behaviours and beliefs that are associated with subjective 
disability and psychological outcome and mediate severity, especially avoidance and 
anticipation of rejection, indicate that these may be suitable for targeted intervention. 
Research has suggested that social support, avoidance and alcohol use influence the 
distress due to living with psoriasis. 
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4 STRESS AND COPING 
4.1 Model of stress and coping 
Lazarus and Folkman (1984) presented a transactional model of stress and coping which 
can serve as a theoretical framework for understanding individual interpretation of and 
response to psoriasis. According to their conceptual framework, perceived stress consists 
of three processes: primary appraisal - perception of threat; secondary appraisal -
evaluating available responses to the threat; coping - carrying out a response. These 
processes do not necessarily take place sequentially, but operate in a continuous cycle of 
appraisal and reappraisal. Therefore perception of stress and response to it are 
represented as ongoing transactions between the individual and the environment. 
Primary appraisal may result in an event being perceived as irrelevant, benign, or 
representing threat - loss, harm or challenge - where coping efforts need to be mobilised. 
The outcome of these processes are governed by complex interacting factors such as the 
degree of importance of threat or outcome, extent of helplessness and individual beliefs. 
However, the model emphasises that no single appraisal or coping response is inherently 
superior, rather that adaptive coping is a dynamic process, responsive to changing 
context. 
A number of coping strategies may be used simultaneously with perceived changeability 
of stressor a crucial variable in predicting whether problem focused coping strategies, or 
emotion focused strategies such as acceptance and denial, are utilised. These two main 
coping strategies were distinguished by Lazarus and Folkman (1984), but Carver et al 
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(1989) believed that this distinction was too simple. As a result they devised a coping 
scale consisting of 15 subtypes of coping response. 
This model of stress and coping emphasises the importance of a correct match between 
choice of coping strategy and changeability of stressor. Chronic medical conditions 
consist of both controllable and uncontrollable aspects (Antoni, 1997) and the model has 
been applied to coping with chronic illness and physical trauma. Kennedy et al (1995) 
conducted a cross sectional analysis of coping strategies used by patients six weeks and 
four to seven years following spinal cord injury. In both groups, quality of social support 
was negatively associated with psychological distress and acceptance was the most 
important predictor of better psychological adjustment. Behavioural disengagement, 
venting emotions, denial and alcohol/substance use were associated with worse 
psychological adjustment. In a longitudinal study, Kennedy et al (in press) found that 
these strategies emerged as significant predictors of anxiety and depression. Further, that 
they were consistent over time and predicted 67% of the variance on depression at one 
year follow up, indicating a causal link between coping strategies and emotional distress. 
Coping strategies have also been investigated in populations of HI V positive men where 
disengagement, denial and alcohol use, and low treatment adherence were all 
significantly associated with poor immune system status and accelerated disease 
progression (Antoni, 1997; Chesney et aI, 1996). 
In chronic health conditions, which involve both controllable and uncontrollable 
stressors, adaptive coping - a good fit between choice of strategy and changeablility of 
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stressor - has been empirically defined as consisting of: acceptance, active coping, 
positive reinterpretation, planning. Maladaptive coping - a poor fit between choice of 
strategy and stressor - has been empirically defined as behavioural and mental 
disengagement, denial, focusing on and venting emotions, alcohol and drug use (Antoni, 
1997; Kennedy et alI995). Kennedy et al (in press) found that more adaptive than 
maladaptive strategies were used overall in the sample of patients with spinal cord injury. 
4.2 Summary 
Adaptive coping has been defined as a good match between stressor and choice of coping 
strategy, maladaptive coping as a poor match between stressor and choice of coping 
strategy. Certain coping strategies in chronic health conditions involving both 
controllable and uncontrollable aspects have been empirically defined as adaptive and 
maladaptive: 
Adaptive coping - acceptance, active coping, positive reinterpretation, planning. 
Maladaptive coping - behavioural and mental disengagement, denial, focusing on and 
venting emotions, alcohol and drug use. 
4.3 Development and application of Coping Effectiveness Training 
Folkman et al (1991) developed a group based intervention termed Coping Effectiveness 
Training (CET) which was derived from the cognitive theory of stress and coping 
outlined in section 4.1. The focus of the intervention is on encouraging adaptive coping 
by matching choice of coping strategy to the extent to which stressful situations can be 
changed. The authors contrast their approach to stress management groups, which teach 
a range of general skills and do not emphasise the "fit" of coping strategy to specific 
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stressor (Chesney et aI, 1996). The original version of their coping effectiveness 
intervention utilised two phases, training and maintenance. Six components constituted 
the intervention: appraisal of stressors, problem and emotion focused coping; fit between 
situation and coping strategy; use of social support; maintenance training and workbook 
exercises. 
There is a developing body of empirical evidence for the effectiveness of CET as an 
intervention in chronic health conditions. Chesney et al (1996) conducted a randomised 
clinical trial of CET with HIV positive homosexual men. Two control groups were used, 
a general information group and a waiting list control. The study was completed by 84% 
of participants. The discontinuers were found to be significantly more anxious and less 
optimistic on initial measures than those who completed the study. Significant 
reductions in perceived stress and burnout, and significant increases in self efficacy, were 
found in CET relative to both control groups. Within group analyses found a reduction in 
anxiety and a trend for a reduction in depression. Antoni (1997) conducted a pilot study 
aimed at reducing maladaptive coping strategies of behavioural and mental 
disengagement and denial, and increasing adaptive strategies of active coping, planning 
and acceptance in a ten week cognitive-behavioural intervention for asymptomatic HIV 
positive homosexual men. They concluded that distress and depression were reduced. 
In a recent controlled study of the application ofCET to spinal cord injury, King and 
Kennedy (1999) found significantly greater decreases in depression and anxiety in the 
treatment group than the control group which were maintained at six week follow up. No 
significant changes in coping strategy were obtained, with the exception of 
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"acceptance", which decreased significantly in control group and was maintained in the 
treatment group. 
Therefore there is evidence that CET may be an effective intervention in chronic health 
conditions in reducing levels of psychological distress. 
4.4 Previous interventions for people with psoriasis 
The mutual support and shared experiences that a group setting offers have long been 
recognised as valuable in a condition where stigma and isolation predominate (Logan 
1985, cited in Burr & Gradwell 1996). The main function of support groups established 
for psoriasis sufferers therefore has been to increase social support and reduce isolation 
(Ginsburg, 1995). In these groups, some of which were initiated by nurses perceiving a 
need for such help for sufferers, members reported increased confidence and believed that 
it had been beneficial to share their feelings (Burr & Gradwell, 1996). 
The few evaluated group based interventions in the literature can be generally subdivided 
into those concerned with the effect of psychological intervention on condition severity 
directly, and those interested in psychological outcome measures. Most interventions 
aimed at reducing severity of condition via the impact of stress on the condition have 
focused on techniques such as stress management, relaxation and guided imagery, either 
on an individual (Zachariae et aI, 1996) or group (Keinan et al, 1996) basis. There are 
several case report examples of stress management alleviating the symptoms of rash in 
atopic dermatitis (Halford & Miller, 1992). Keinan et al (1995) explored the effects of 
relaxation and biofeedback groups on psoriasis severity, relative to a waiting list control 
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group. The group receiving relaxation and biofeedback self-reported greater symptomatic 
improvement relative to the same season of the previous year, but not relative to the start 
of treatment, than controls. The authors attributed these findings to the major seasonal 
fluctuation of psoriasis and concluded that combined relaxation and biofeedback may be 
an effective way to help to reduce the symptoms of psoriasis. 
Of the studies focusing on psychological, as well as medical, outcome variables, few 
have used control groups. Ehlers et al (1995) drew attention to the lack of controlled 
studies in this area and provided an example of a well designed randomised controlled 
study of patients with atopic dermatitis. Patients were randomly allocated to one of five 
groups: education programme; relaxation; cognitive-behavioural intervention consisting 
of relaxation and training in problem solving and assertiveness, a combination group of 
education plus cognitive behavioural, and a control group receiving standard medical 
care. The groups consisted of 12 weekly sessions of one and a half hours and had 
between five to seven participants. Scores were compared on a range of measures of 
psychological well-being - depression, anxiety, atopic dermatitis related distress - as well 
as medical measures of skin severity. The group receiving education combined with 
cognitive behavioural intervention showed a significant decrease in anxiety at the end of 
treatment, sustained at one year follow up. There was also a reduction in frequency of 
catastrophising cognitions in all the treatment groups relative to the control group, and, 
at follow up, a significantly larger improvement in skin condition in the treatment groups. 
Of the group based studies in psoriasis, only two could be found which attempted to use a 
control group. The most recent, Price et al (1991), used two weekly eight week groups 
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led by a clinical psychologist. Patients were randomly assigned either to treatment or 
control group. Fifteen patients were initially assigned to a group, of which 11 patients 
completed the groups, with 12 in the control group. Mean age was 46 years and mean 
duration of psoriasis 25 years. The group included relaxation, and discussion of aspects 
of the difficulties posed by psoriasis, and the effect on self concept and self esteem. 
Measures of depression, anxiety, self esteem, and social adjustment were taken pre and 
post intervention and at six month follow up. There was a significant group * time 
interaction effect for anxiety, the treatment group decreasing in anxiety scores, which was 
sustained at six month follow up. In Bremer Schulte et aI's study (1985), a physician and 
patient trained together to facilitate 10 weekly two hour sessions (duo formula group 
treatment) focused on self care and stress management. Treatment groups consisted of 
seven members and there was a waiting list control of 14 members. A questionnaire was 
constructed concerning aspects of illness behaviour, shame, problem solving, 
assertiveness. The authors did not subject the results to ANOV A's but between group 
analyses of score changes showed significant decreases in illness behaviour, shame and 
shyness in the treatment group, along with increases in interactional skills and problem 
solving. 
In addition, Abel et al (1990) reported on the content of an open ended non controlled 
weekly support group run for patients at a Psorias day care centre in the U.S.A., led by a 
psychiatrist. Common themes included loneliness and isolation, altered self-image, 
interpersonal relationship difficulties, changes in personal habits, career choice, medical 
concerns. Kang Seng et al (1997) reported on a non controlled pilot project in Singapore 
of seven sessions with a group of ten self selected psoriasis patients, either members of 
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the association or from the medical caseload. A structured format was used, including 
topics of understanding psoriasis, acceptance, anxiety and stress, daily hassles of 
psoriasis, medical aspects. In each session a case study fuelled discussion. No formal 
measures were used but a subjective questionnaire suggested that participants had found 
the group useful in increasing their knowledge and acceptance of the condition. 
Despite the clear psychological impact of psoriasis, the potential benefits of group 
treatment, and the encouraging results from some studies undertaken, there is evidence 
that psoriasis patients are difficult to engage in psychological treatment approaches. 
Fortune et al (1998) investigated the reasons for poor uptake of a cognitive behavioural 
intervention programme at a tertiary psoriasis clinic: of 87 eligible patients, only 10% of 
those who were invited eventually took part in the programme. By comparing initial 
scores between those who subsequently took up the psychological programme and those 
who did not, they found significant differences on measures of beliefs about severe 
consequences of psoriasis, pathological worry and feelings of stigmatisation, with 
pathological worry best predicting non uptake of service in patients who initially agreed 
to participate. 
4.5 Summary 
Evidence from the few group interventions suggests their use in reducing emotional 
distress, particularly anxiety, and enhancing quality of life in'patients with psoriasis. 
However to date there have been few controlled studies derived from a specific 
theoretical rationale and none which have aimed to match coping strategy to 
changeability of stressor, which would seem to be important in a fluctuating condition 
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consisting of controllable and uncontrollable aspects. There is evidence that psoriasis 
patients are a hard group to engage in group interventions, hindered perhaps by the very 
difficulties which such groups would attempt to address. 
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5 OUTLINE OF STUDIES 
5.1 Outline of study one 
5.1.1 Rationale 
Psoriasis has been shown to have a clear impact on quality of life. The literature has 
identified several variables mediating the impact of psoriasis on subjective disability and 
psychological distress, in addition to medical severity. There is some evidence that these 
mediating factors may influence psoriasis, either directly, via proposed links with the 
immune system, or indirectly via changed behaviours. Research has suggested that 
behaviours and beliefs about the condition are important determinants of subjective 
disability (Fortune et aI, 1997b, Scharloo et aI, 1998) as are certain coping responses such 
as use of social support, seeking information and adhering to treatment regime. Other 
coping responses, such as use of alcohol and avoidance of activities, have been correlated 
with poorer outcome. In many surveys, however, specific coping strategies have not 
been assessed using standardised measures. Fortune et al (1997a, 1997b) found that 
subjective disability was strongly predicted by anticipatory-avoidance behaviours, and 
beliefs in, or experiences of, others' negative evaluations. 
Folkman & Lazarus's theoretical framework has been used to identify specific coping 
strategies which have predicted variance in measures of psychological adjustment in 
other chronic health conditions. Psoriasis is recognised as a chronic condition which 
demands life time coping and adjustment, therefore the theory of appraisal and coping 
would seem to be a useful framework within which to conduct further research. It would 
be useful for further studies to employ standardised coping scales to investigate the 
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association between coping strategies and subjective disability and psychological distress 
in psoriasis. 
5.1.2 Aims of study one 
* Explore the relationship between coping strategies, subjective disability and 
psychological distress in a community sample of adults with psoriasis. 
The four outcome variables used were subjective disability, psoriasis specific stress, 
anxiety and depression. Psoriasis specific stress was measured using the Psoriasis Life 
Stress Inventory and was defined as anticipatory-avoidance behaviour and beliefs in or 
experience of others' negative evaluations. 
It was important to determine if the findings of Fortune et al (1997b) would apply to this 
sample, and to explore further the mediation of coping strategies. Fortune et al (1997b) 
had found that anticipatory-avoidance behaviour, and beliefs in, or experience of, others' 
negative evaluation, best accounted for the variance on a measure of subjective disability. 
* Investigate whether coping strategies are correlated with the other mediating 
variables of age, gender or duration of psoriasis. 
The role of age and gender factors in adjustment to psoriasis have received mixed 
evidence in the literature, and it may be that they reflect the employment of 
systematically different coping strategies which mediate the psychological impact of 
psoriasis. 
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* Identify the coping strategies which could be addressed in a psychological 
intervention. 
The study aimed to determine whether the empirically defined adaptive and maladaptive 
strategies found in the other chronic health conditions also applied to psoriasis, and the 
extent of their influence on outcome variables. 
5.1.3 HyPotheses 
1) Subjective disability will be best predicted by anticipatory-avoidance behaviour and 
beliefs in others' negative evaluations, rather than by age, duration of psoriasis, gender, 
anxiety and depression. 
2) Coping subscales will predict a significant proportion of the variance in the four 
outcome measures. 
3) There will be an association between age, gender, duration of psoriasis and coping 
strategy. 
4) Adaptive coping will be inversely related to scores on thefour outcome measures. 
5) Maladaptive coping will be positively related to scores on the four outcome measures. 
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5.2 Outline of Study two 
5.2.1 Rationale 
Conducted concurrently with study one, this pilot intervention intended to target specific 
coping behaviours and beliefs in psoriasis which have been suggested as mediating 
subjective disability and psychological distress. Coping Effectiveness Training offers a 
framework of a structured group based intervention based on a theoretical rationale, and 
has been shown to be successfully applied in other chronic health conditions. Of the 
psoriasis group programmes reviewed, the components of a structured, educational focus, 
use of relaxation, problem solving and assertiveness, are shared by the format of Coping 
Effectiveness Training, suggesting its appropriateness. However, no study yet seems to 
have addressed match of coping strategies specifically in interventions for people with 
psoriasis. It has been suggested that these coping strategies may be influential variables 
in both subjective disability and psychological distress. It therefore seemed appropriate to 
modify and pilot an intervention derived from Coping Effectiveness Training for this 
group. 
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5.2.2 Aims of study two 
* Investigate whether a community sample of psoriasis sufferers could be engaged 
to attend a weekly Coping Effectiveness Training group. 
* Investigate whether the group improved the outcome on measures of subjective 
disability and psychological distress, and increased adaptive coping, relative to 
controls. 
* Investigate whether the group was perceived to be useful by participants, 
particularly in enhancing coping with psoriasis and reducing emotional distress. 
The four outcome measures were subjective disability, psoriasis-specific stress, anxiety, 
depression. 
5.2.3 Hypotheses 
(hypotheses one to five refer to study one) 
6) Treatment participants will show a significantly greater reduction on scores on the 
four outcome measures than controls. 
7) Treatment participants will show a significantly greater increase in adaptive coping 
strategies (active coping, acceptance, positive reinterpretation, planning) than controls. 
8) Treatment participants will evaluate the groups positively in terms of perceived 
usefulness, relevance and enhancement of coping ability. 
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II: METHOD 
6.1 Participants 
Participants were recruited from the dennatology outpatient clinic and through the local 
Psoriasis Association. All those who suffered from psoriasis and were between 16 and 
70 years of age were considered eligible for the initial questionnaire survey. Patients 
were either known to have a diagnosis of psoriasis, if recruited through the clinic, or self 
reported a diagnosis of psoriasis, through the association. Patients needed to be able to 
understand and complete the questionnaires. 
Participants for the intervention pilot group in study two were a self selected subset of 
those from study one, from either the clinic pool or the association pool, who were 
interested in attending a group, had the means of getting to the hospital site in the 
evening, and were not known to be receiving ongoing psychological treatment. These 
requirements excluded some people who had family or other evening commitments or, 
in some cases, no means of transport. The control group for study two were also 
composed of a subset of study one participants, matched as far as possible for age to the 
intervention group, who expressed a willingness to act as controls in the study. (Some 
had been interested in participating in the intervention, but were unable to attend). Study 
two had originally been planned as a randomised controlled study, but it was recognised 
early on that the sample size would not pennit this, and recruitment was changed to 
inviting those who wished to attend. 
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6.2 Design 
Study one was a cross sectional postal questionnaire design with outcome variables of 
Psoriasis Disability Index (PDI); Psoriasis Life Stress Inventory (PLSI); Anxiety 
(HAD); Depression (HAD) and independent variables of measures of coping strategy, 
age, gender, psoriasis duration. 
Study two was a non randomised controlled pilot study comparing participants in the 
intervention group to the control group on the above range of outcome measures. 
6.3 Measures 
6.3.1 Demographic data 
Information was requested on age, sex, duration of psoriasis, treatment currently 
receiving, marital and occupational status. 
6.3.2 Psoriasis Disability Index (PDI) (Finlay, Khan, Luscombe, Salek 1990) 
The subjective disability due to psoriasis was assessed using this fifteen item self report 
measure answered on a visual analogue scale graded from 0 to 6, ranging from "not at 
all" to "very much". The questions form five subsets; daily activities (five items), work 
or school (three items), personal relationships (two items), leisure (four items), 
treatment (one item). Patients are asked to consider how the disease has affected them in 
these areas over the previous month when completing the measures. The PDI score is 
calculated by summing the responses and provides an overall measure of subjective 
disability which can range from 0 to 90. A higher score indicates greater quality of life 
impairment. 
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The PDI has well established reliability, for example, test-retest reliability (Finlay & 
Kelly, 1987) and has been validated against the Sickness Impact Profile - a detailed 
general measure of the impact of disease - (Finlay, Khan, Luscombe, Salek 1990). Kent 
& Abadie (1993) factor analysed the scale and compared responses from individuals 
with psoriasis and other skin conditions. Their results showed that the items were 
effective in discriminating between psoriasis sufferers and patients with other skin 
conditions. 
6.3.3 Psoriasis Life Stress Inventory (PLSI) (Gupta & Gupta 1995). 
This fifteen item scale provides a rating of the recurrent stress associated with living 
with psoriasis. Each item is measured on a four point scale, a score of 0 indicating "not 
at all" and a score of 3 indicating "a great deal". The overall score provides a measure of 
psoriasis related stress which can range from 0 to 43. A score of greater than or equal to 
1 0 is taken as high stress, less than 1 0 low stress. When completing the questionnaire, 
patients are instructed to consider their psoriasis related experiences over the last month. 
The scale was constructed from endorsements of217 patients with a wide range of 
psoriasis severity. The scale has high internal reliability, Cronbach's alpha for allIS 
items was 0.9, and good construct validity, with a direct correlation between PLSI score 
and patient self rating of psoriasis severity in different body regions. 
Fortune, Main, O'Sullivan et al (1997a) subjected the scale to a factor analysis and 
identified two factors: stress due to anticipatory-avoidance coping behaviour, and to 
beliefs or experience of negative evaluation by others. 
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6.3.4 Hospital Anxiety and Depression Scale (HAD) Zigmond & Snaith (1983) 
This 14 item self report scale is designed to be used in non psychiatric populations 
where physical illness may affect the scores on traditional measures of depression and 
anxiety. The questionnaire consists of two subscales, each of seven items, yielding a 
separate score for anxiety and depression. Questions are answered on a four point scale, 
a score of 0 indicating "not at all" and 3 indicating maximum agreement. Patients are 
requested to respond according to how they have been feeling in the previous week. The 
cut off for clinically significant levels of anxiety and depression can be taken as either 8 
or 10. Eight indicates possible clinical levels of anxiety or depression, ten indicates 
probable clinical levels of anxiety or depression. Ten was used as cut off in the current 
study. The scale has been validated against interview ratings, and has good internal 
reliability (Zigmond & Snaith 1983). 
6.3.5 COPE scale (Carver, Scheier, Weintraub (1989) 
This is a 60 item self report measure of coping strategies. It is divided into 15 
subscales, each consisting of 4 items, scored on a one to four point scale, with 1 
representing "not used / hardly ever" and 4 representing "very frequently". The 
subscales are: active coping, planning, suppression of competing activities, restraint 
coping, seeking instrumental social support, seeking emotional social support, positive 
reinterpretation and growth, acceptance, religion, focus on and venting emotions, denial, 
behavioural disengagement, mental disengagement, use of alcohol/drugs, humour. 
For each strategy, a score of between 4 and 16 may therefore be obtained. The COPE 
has well established psychometric properties (Carver et aI1989). The COPE may 
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either be used as a situational measure, coping with a specific situations or events, or as 
a dispositional measure. As psoriasis is chronic and relapsing, and the current state of 
psoriasis was not known, subjects were asked to respond according to how they believed 
they generally coped with psoriasis. 
6.3.6 Participants evaluation of the intervention 
A short questionnaire was designed by the researcher to ascertain how useful the 
intervention was perceived to be. Questions using a 0 to 5 visual analogue scale were 
devised on: whether the group was useful; whether participants' concerns were 
addressed; whether participants felt able to express their concerns in the group context; 
whether participants felt more able to cope with their condition. There was also space 
for general comments, a question on what was perceived to be most useful/least useful 
and whether any new or different coping strategies were going to be employed. 
6.4 Procedure 
6.4.1 Contact and liaison with nursing and dermatology staff 
Following meetings with the consultant dermatologist in the early stages of this project, 
a file was established of all the referrals to the outpatient clinic who had a diagnosis of 
psoriasis, dating back the previous six months. This was updated as new referrals were 
added. 
The researcher attended an outpatient clinic, workshadowing the consultant, to gain 
increased understanding of medical aspects of the condition and the type of concerns 
expressed. A room for the group meetings was arranged in the dermatology ward, a 
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setting familiar to some of the participants. Infonnal meetings with the nurses on the 
ward were held in order to discuss the project and receive suggestions. 
6.4.2 Recruitment for study one 
There were two sources of recruits: from the dennatology outpatient clinics and from 
the psoriasis association. These were both initiated to collect a sufficient pool of people 
for a group intervention to be feasible. 
Clinic recruits: following ethical approval, everyone with a diagnosis of psoriasis who 
had received outpatient treatment within the previous six to eight months and who was 
between 16 years to 70 years of age, was contacted by post. An outline of the study was 
given, and a reply slip enclosed for those interested in hearing more to respond 
(Appendix 2). Those interested were requested to send the reply slip back in the prepaid 
envelope with their address and telephone number. Those who were not interested 
needed to take no action. 
A post box for reply slips was also left in the dennatology outpatients reception area. 
Nurses gave out the explanatory sheets at the fortnightly clinics to those patients who 
had a diagnosis of psoriasis. Any patient who was interested in hearing more was 
requested to fill in the reply slip with their name and address and leave it in the post 
box. 
Association recruits: the chainnan of the local branch of the psoriasis association had 
been contacted by post and expressed his support and interest. The researcher attended a 
psoriasis association committee meeting and presented the project to the committee. The 
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study outline, a reply slip and stamped addressed envelope, were then sent out with the 
next association newsletter to all their registered members. A paragraph in the 
newsletter from the chairman endorsed the study. As a significant proportion of 
members of the association were also likely to be attending the dermatology outpatient 
clinics, recruits were also asked not to duplicate their response. 
All mail for the researcher was addressed to the care of the consultant dermatologist. A 
tray in the dermatology secretary's room was established for the research mail. 
All those who replied indicating that they were interested in hearing more were 
contacted by telephone by the researcher. A convenient time was arranged to discuss 
the study if the time telephoned was not convenient. In the telephone conversation, the 
proposed study, both the survey and the group, were outlined stressing that the study 
was concerned with understanding how people coped with living with psoriasis and the 
difficulties it presented for them. The intervention group was emphasised as one 
utilising a structured focus on coping and problem solving, and as a forum to share 
concerns and ideas with other sufferers. The call ended by discussing any questions or 
queries from the potential participant. Those who were willing to complete the 
questionnaires, initially whether or not interested in the group, were sent the 
questionnaires by post along with an information sheet and consent form, and stamped 
addressed envelope (Appendices 3,4 and 5). A contact teletelephone number was 
included. All questionnaires were coded to preserve anonymity. 
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6.4.3 Recruitment for study two 
This was initiated once the first set of questionnaires had been received. Those who 
had expressed an interest in the intervention were then telephoned again, as had 
been outlined and agreed in the first telephone call. Optimum weekday evenings were 
sought from each person, and a consensus reached. Those unable to attend on the night 
selected were asked if they wished to wait for possible inclusion in a subsequent group, 
if still interested (three groups were run in total). The time interval between receipt of 
questionnaires and start of the group was between four and six weeks. Ifparticipants 
decided to join a later group, they were sent a repeat set of questionnaires a month 
before the start ofthe later group. For those not able to attend, they were asked if they 
would be willing to act as controls for the study and complete an additional set of the 
questionnaires once the first group had been completed. 
Once the arrangements for the group intervention were finalised, the participants were 
again contacted by telephone and final details confirmed, including parking, directions, 
and the number of people in the group. It was also a time when any final queries or 
concerns could be raised with the researcher. 
These telephone conversations enabled a relationship to be established between the 
researcher and participants before the start of the intervention, and for the researcher to 
gain some understanding of the specific concerns of various group members. 
Those who had expressed a willingness to act as a control were sent the repeat 
questionnaires two months later along with a letter reminding them of the nature of the 
study (Appendix 6). A summary of the results was promised to those who indicated that 
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they would be interested in receiving this. In an attempt to match age range as far as 
possible when matching numbers in the treatment and control groups, the researcher 
excluded the oldest two participants who had been willing to be in the control group, 
although their first set of questionnaires were still used for analysis in study one. 
The recruitment took place in two phases, the first phase consisted of the postal requests 
to outpatient sample, and the second phase the postal requests to the psoriasis 
association sample, although recruitment through attendance at the clinic was ongoing 
throughout this time. Intervention groups two and three were recruited using the same 
procedure as intervention group one, outlined above. As most of the hospital 
outpatients were approached first, the first intervention group consisted mainly of the 
hospital recruits while the second and third groups consisted mainly of the association 
recruits. However, there was some overlap due to discontinuers and some initial 
hospital recruits joining a later group if it was more convenient. 
Those who failed to attend the groups or discontinued were still included in the overall 
sample for study one, as initial questionnaires were received before the intervention 
commenced. 
6.4.4 Intervention groups 
Each group was held on the same weekday night - Tuesday for the first two groups and 
Monday for the third - in the dermatology ward. The ward has beds for eight inpatients 
and so had nurses on duty during the time the groups were running. The groups were 
held in the day room in the ward. Handouts for each week were given. Those who had 
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missed a meeting were given the handouts the following week, with opportunity to 
discuss them. 
6.5 Ethical considerations 
6.5.1 Ethics approval 
Ethics approval was sought and obtained from the local research ethics committee. 
See Appendix 1. 
6.5.2 Arrangements for distress 
Participants in the group interventions were given the researcher's telephone number in 
case they were unhappy with any part of the group. The number of the dermatology 
ward was also given so that messages, for example, of people unable to attend, could be 
left. In addition, people were encouraged to contact their G.P. ifit was felt that 
individual help would be of benefit. This was emphasised in the group in general and 
also discussed individually with one participant at the end of a group meeting. If a 
participant missed a group without leaving a message, they were contacted by the 
researcher to ensure that they were not left distressed as a result of a group, and to 
discuss whether they wished to continue. It was emphasised that they were free to 
withdraw from the study at any point. At the end of the groups, all participants were 
asked to provide feedback. 
During the initial recruitment telephone calls, if it was felt that people were 
experiencing difficulties they were encouraged to seek help from their G.P. 
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6.6 Construction of the group programme 
Theoretical information was available from published literature on the general content 
of other psoriasis interventions. Clinical information was obtained through the 
dermatologist and ward nurses at the outpatient clinic where the groups were to be held. 
Knowledge was also obtained from a psychologist experienced in working with people 
with psoriasis at a tertiary clinic. From these sources, ideas ofthe concerns relevant to 
patients with psoriasis were generated. Group material was also taken from other 
sources: problem solving (Hawton & Kirk, 1989); challenging thoughts and 
assumptions (Greenberger & Padesky, 1995); panic and anxiety (Clark, 1989); shame 
(Gilbert 1997); assertiveness (Powell, 1992). Following completion of a draft version, 
the proposed content was reviewed with the chairman of the local psoriasis association, 
himself a sufferer, to ensure that the final programme was appropriate to the concerns of 
psoriasis sufferers. 
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6.7 Content of the group programme 
Following the format of King & Kennedy (1999) the group programme consisted of 
seven sessions of about 75 minutes, run weekly. Each session was structured and 
covered a particular theme, beginning with a review of the week before. Although 
structured, there was time in each group for group discussions around the themes raised. 
A more detailed summary ofthe intervention content can be found in Appendix 8. 
Session 1: Concept of stress; typical reactions to it; living with psoriasis as a source of 
stress; introduction to appraisal and coping. 
Session 2: Appraisal, identifying and breaking down problems; coping by changing the 
situation or by changing our reactions to the situation. Coping with psoriasis as one of 
multiple demands on resources, energy and time. 
Session 3: Problem solving. Typical problem scenarios of awkward social situations, or 
experiences ofrejection used to generate ideas and discussions. 
Session 4: Emotional reactions, depression and anxiety. The cycle of panic and 
cognitive behavioural model of panic attacks. Link between thoughts, feelings and 
behaviour. List of behaviours which elevated self esteem, mood and confidence. 
Relaxation tapes issued to group participants. 
Session 5: Negative assumptions. Focus on self concept, role of psoriasis in 
development of self concept. Shame and its role in psoriasis. Effects of assumptions on 
current thoughts and emotions ,and idea of challenging assumptions introduced. 
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Session 6: Coping with psoriasis. Commonly used strategies; differences due to age, 
culture, and gender. Importance of flexibility in fluctuating condition. Effects of 
maladaptive coping, in particular the cycle of withdrawal and avoidance. 
Session 7: Use of social support and the difference between assertive, passive and 
aggressive modes of interaction. Practice of assertiveness skills and discussion of 
contexts which moderated their use. 
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III RESULTS: OVERVIEW OF DATA ANALYSIS 
The analysis of results is divided into three sections. Section 7 presents the sample 
characteristics and representativeness. Section 8 presents the results for study one, and 
section 9 presents the results for study two. 
The following analyses were conducted for each of the investigations. 
Section 7 Sample characteristics and representativeness: The questionnaire measures all 
used equal interval scaling and consisted of subscales of at least four items, so provided a 
spread of data distribution. However, the further assumption for parametric 
t tests comparing means - that the population from which the sample is drawn has a 
normal distribution - could not be assumed for these variables. For this reason, non 
parametric, Mann-Whitney U tests were conducted on the data comparing two means. 
Where three means were to be compared, a Kruskal Wallis test was used. 
Section 8 Hypothesis one: Subjective disability will be best predicted by anticipatory-
avoidance behaviour and beliefs in others' negative evaluations, rather than by age, 
duration of psoriasis, gender, anxiety and depression. 
Hypothesis two: Coping subscales will predict a significant proportion of the variance in 
the four outcome measures. 
For the analyses of predicting variables a series of parametric stepwise multiple 
regressions were run. Concerns of the normality of the measurements do not apply for the 
regressions, but the assumption that the residuals are normally distributed was tested by 
conducting Kolmogorov-Smimofftests on each. All residuals were found to be normally 
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distributed. In addition scatter plots were undertaken of residuals against predicted 
values to test the assumption of constant variance. In all cases this assumption held. 
Hypothesis three: There will be an association between age, gender, duration of 
psoriasis and coping strategy. 
Hypothesis four: Adaptive coping will be inversely related to scores on the four outcome 
measures. 
Hypothesis jive: Maladaptive coping will be positively related to scores on the four 
outcome measures. 
A series of parametric Pearson correlation coefficients were calculated on the variables. 
The same assumptions applied as for multiple regressions. 
In order to test for effects due to gender, where only two values are possible, non 
parametric Mann Whitney U tests were conducted, comparing the mean scores for males 
and females on outcome measures and coping strategies. 
Section 9 Hypothesis six: Treatment participants will show a significantly greater 
reduction on scores on the four outcome measures than controls 
Hypothesis seven: Treatment participants will show a significantly greater increase in 
adaptive coping strategies than controls 
To test these hypotheses, a series of repeated measures ANOYA's were conducted. 
While these also assume normality of measurements, they are robust to departures from 
normality. The number of ANOYA's conducted on the same data set - 15 subscales of 
the COPE and four outcome variables, increased the risk of a type one error. 
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Hypothesis eight: Treatment participants will evaluate the intervention group positively 
in terms of perceived usefulness, relevance, and enhancement of coping ability. 
As the feedback questionnaire, constructed by the researcher, could not be assumed to 
fulfil the assumptions for parametric tests, non parametric Kendall's correlation 
coefficients were used to correlate the change in score on the outcome measures with 
subjective ratings on the feedback questionnaire. 
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RESULTS: SAMPLE CHARACTERISTICS AND REPRESENTATIVENESS 
7.1 Demographic data 
The participants were drawn from two sources, the Dermatology hospital outpatient 
clinic, both through a postal request and through attendance at the clinic, and by post 
through the Psoriasis Association (self help group). Response rates are shown for each of 
these sources, and for the whole sample. 
7.1.1 Response rates 
Table 1 gives the response rates for each stage in the recruitment. Initial overall response 
, I 
rates of 45% are comparable to other surveys for this population (Finlay & Coles 1995). 
The slightly lower rate from the association may have been due to duplication - some 
people would also have been attending the dermatology clinic. The high response rates of 
80% for questionnaire returns reflects the fact that contact had already been made with 
the respondents by telephone and questionnaires were only issued to the people who had 
agreed to receive them. 
Table 1: Response rates 
Sample Total Replies Response Q'aires Q'aires Response 
requests N N rates % sent N received N rates % 
Clinic olp not known 19 nla 19 12 63% 
Clinic postal 118 51 43% 36 31 86% 
Association 220 81 37% 56 46 82% 
TOTAL 338 151 45% III 89 80% 
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7.1.2 Sample Characteristics 
Table 2 gives the mean age, duration of psoriasis and gender distribution for the sample. 
A mean age of 49.7 years is slightly higher than for other studies in this population. 
Psoriasis duration is similar, and the sex distribution is consistent with other studies 
(Koo 1996; McHenry & Doherty 1992). Of the sample, 53.9% were employed, 42.7% 
not in paid employment. 74.2% were married or living with a partner, 10.1 % single, 
7.8% divorced and 5.6% widowed. There was no occupational or marital status 
information for two of the participants. In terms of treatment 10.1 % were currently 
having or had received phototherapy in the last month, 15.7% were taking systemic 
medication 61.8% using topical creams / steroids, and 18% no treatment currently. Some 
people were using a combination of treatments so the figures do not add to 100%. 
Table 2: Gender distribution, means and standard deviations of age and psoriasis 
duration for clinic, association and whole sample. 
Clinic Association Whole sample 
N=43 N=46 N=89 
Age/yrs 48.7 (13.8) 50.9 (15.5) 49.7 (14.7) 
Duration psoriasis / yrs 22.0 (16.1) 33.3 (17.2) .. 28.1 (17.6) 
Sex: Male 17 16 33 
Female 26 30 56 
•• p<O.OI 
Non parametric Mann Whitney U tests were conducted to test for differences on the 
above variables between the two sample sources. There were no significant age 
differences, but duration of psoriasis was significantly longer in the association sample 
than the clinic sample. Gender distribution was tested using a chi square analysis. There 
were no significant gender differences. 
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7.1.3 Match between association and clinic samples 
As participants were recruited from two different sources, tests were conducted on the 
mean scores on all the questionnaire measures to check whether the two sources could be 
combined into one sample for analysis. Table 3 gives the means and standard deviations 
for each questionnaire measure for both sources separately and the whole sample. 
Table 3: Means and standard deviations of variables for association, clinic and 
whole sample. 
Clinic Association Whole sample 
(N=43) (N = 46) (N= 89) 
Subjective disability (POI) 24.9 (21.2) 16.5 (16.5) 20.7 (19.3) 
Psoriasis-stress (PLSI) 16.4 (12.0) 15.2 (10.2) 15.8 (1Ll) 
Anxiety (HAD) 8.1 (5.8) 5.7 (4.7) 6.9 (5.7) 
Depression (HAD) 7.4 (4.1) 6.0 (4.3) 6.7 (4.2) 
COPE SUBSCALES (N =42) (N = 44) (N - 86) 
Restraint 8.0 (3.2) 8.2 (2.8) 8.1 (2.9) 
Positive Reinterpretation 8.8 (3.3) 10.3 (3.3) 9.7 (4.4) 
Active coping 10.0 (3.7) 10.5 (3.1) 10.3 (3.4) 
Planning 9.1 (3.5) 10.3 (3.6) 9.8 (3.6) 
Emotional social support 8.8 (3.1) 7.9 (3.4) 8.2 (3.2) 
Instrumental social support 8.8 (3.6) 8.3 (3.4) 20.7 (19.2) 
Suppress competing activities 7.9 {3.3) 8.2 (3.0) 8.1 (3.1) 
Religion 6.7 (4.1) 6.4 (3.2) 6.5 (3.5) 
Acceptance 11.4 (3.6) 11.9 (2.9) 11.7 (3.2) 
Mental disengagement 7.5 (3.0) 7.4 (2.8) 7.4 (2.9) 
Vent emotions 8.7 (4.3) 7.4 (3.0) 8.0 (3.6) 
Behavioural disengagement 6.8 (3.4) 6.0 (2.0) 6.3 (2.7) 
Denial 6.0 (2.5) 5.7 (2.1) 5.8 (2.3) 
Alcohol 5.1 (2.5) 5.3 (2.9) 5.2 (2.7) 
Humour 6.6 (2.6) 6.5 (2.9) 6.5 (2.8) 
There were no significant differences between association and clinic samples on any of 
the above measures. They were therefore combined into a single sample for analysis. 
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7.1.4 Levels of clinically significant distress 
The percentage of the sample suffering from clinically significant distress was evaluated, 
taking a score of greater than or equal to 10 as cut off for anxiety and depression, to 
indicate probable clinical levels, and 10 as indicating high stress on the psoriasis life 
stress inventory. The results are shown in Table 4. 
Table 4: Levels of clinically significant distress 
Clinic Association Whole sample 
N % N % N % 
Psoriasis-stress (PLSI) 24 55.8 31 67.4 55 62 
Anxiety (HAD) 15 34.9 9 19.6 24 27 
Depression (HAD) 13 30.2 11 23.9 24 27 
Of the whole sample, 27% were significantly depressed and anxious (although the 
composition of individuals differed between the two measures). In addition, 62% were 
experiencing a high degree of distress related to their psoriasis. These figures were 
consistent with the research findings (McKenna & Stem 1997). 
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8 STUDY 1: DATAANALYSIS 
A series of stepwise mUltiple regressions were undertaken to determine the variables 
predicting subjective disability and emotional distress. In all the regressions that follow, 
checks were carried out that the assumptions of parametric tests held: Kolmogorov-
Smimoff to test that residuals were normally distributed; scatter plots of residuals 
against predicted values to ensure equal variance. 
8.1 Predictors of subjective disability 
Hypothesis 1: Subjective disability will be best predicted by anticipatory-avoidance 
behaviour and beliefs in others' negative evaluations rather than by age, duration of 
psoriasis, gender, anxiety and depression. 
As a preliminary measure, a Pearson correlation matrix of the outcome and demographic 
variables suggested that these were all, except gender, significantly associated 
(to p<0.05) with SUbjective disability: age (r = -0.22, p<0.05); 
duration of psoriasis (r = -0.21, p<0.05); psoriasis-stress (r = 0.8, p<O.O 1); 
anxiety (r = 0.49, p <0.01); depression (r = 0.44, p<O.OI). Gender not included in the 
correlation matrix as only two values were possible. 
Two stepwise multiple regressions were performed with subjective disability as the 
dependent variable. All the other outcome measures, coping strategies and the above 
demographic variables were selected for inclusion in the regression analysis. 
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In the first regression, the measure of psoriasis-specific stress, which consists of 
anticipatory-avoidance behaviours, and beliefs in others' negative evaluation, was 
entered as a single variable, with one single overall score. 
The best model contained three variables which were entered in the following order: 
Psoriasis-specific stress accounting for 67% of the variance 
(F=151.2, R square = 0.67, p<O.OOl), venting emotions accounting for a further 4% of the 
variance (F=89.5, R square = 0.71, p<O.OOl) and gender a further 3% of the variance 
(F=68.9, R square =.0.74, p<0.004). 
In the second regression, psoriasis-specific stress was split into the two factors of 
anticipatory-avoidance behaviour and beliefs in others' negative evaluations, using the 
factor solution of Fortune et al (1997a). In this model, behaviours accounted for most of 
the variance, 59% (F=107.1, R square = 0.59, p<O.OOI), venting emotions a further 9% of 
the variance (F=76.1, R square = 0.68, p<O.OOl), gender a further 3% 
(F=57.3, R square = 0.71, p<0.003) with beliefs in others' negative evaluation accounting 
for an additional 3% (F=49.7, R square = 0.74, p<0.005). 
Therefore the variance is most strongly predicted by anticipatory-avoidance behaviour as 
found in the analysis of Fortune et a1 (l997b). Beliefs in others' negative evaluations 
accounted for an additional 3% after venting emotions and gender. 
Hypothesis one was partly confirmed. Overall, anticipatory-avoidance behaviours and 
beliefs in others' negative evaluations accounted for 67% of the variance on subjective 
disability - the single best predictor. The behaviour component of psoriasis-specific stress 
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alone best predicted subjective disability. Beliefs in others' negative evaluations added a 
small, but significant independent contribution which was not as important in accounting 
for the variance in SUbjective disability as venting emotions or gender. 
8.2 Coping strategies 
Hypothesis 2: Coping strategies will predict a significant proportion of the variance on 
the four outcome measures. 
The preliminary Pearson correlation coefficients of demographic variables in Table 5 
show that in this sample age was significantly inversely correlated with anxiety, 
subjective disability, and psoriasis-specific stress. Duration of psoriasis was significantly 
correlated with anxiety, and with subjective disability, but not with psoriasis specific 
stress or depression. These were therefore entered into the appropriate regresssion 
analyses. 
Table 5: Pearson correlation matrix: age, duration of psoriasis and outcome 
variables. 
Age Psoriasis 
Duration 
Subjective disability (POI) 
-0.219* -0.214* 
Psoriasis-stress (PLSI) 
-0.264* -0.177 
Anxiety (HAD) 
-0.300** -.0289** 
Depression (HAD) 
-0.145 -.0184 
* p<O.OS, **p<O.Ol 
To conduct the regression analyses, the outcome measures were each selected in turn as 
dependent variables while the other three were excluded from the analysis. This was in 
order to eliminate the strong reciprocal relationship between the outcome variables 
themselves, and to allow the influence of coping strategies and age, gender and psoriasis 
duration to be examined. 
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8.2.1 Subjective disability as the dependent variable. 
A three variable model accounted for most of the variance, with the variables entered in 
the following order: Venting emotions 36% (F=41.2; R square = 0.36, p<O.OOI); Alcohol 
4% (F=24.l, R square = 0040, p<0.05); Mental disengagement 3% (F=18.0, R square = 
0.43, p<0.05). 
8.2.2 Psoriasis-specific stress as the dependent variable. 
A three variable model accounted for most of the variance, with the variables entered in 
the following order: Venting emotions 28% (F=28.3, R square = 0.28, p<0.002); Alcohol 
6% (F=18.5, R square = 0.34, p<0.02); Mental disengagement 4% (F=14.7, R square = 
0.38, p<0.05). 
8.2.3 Anxiety as the dependent variable 
A five variable model accounted for most of the variance, with the variables entered in 
the following order: Venting emotions 48% (F=66.8, R square = 0.48, p<O.OOl); 
Duration of psoriasis 6% (F=42.0, R square = 0.54; p<0.005); Disengagement 4% 
(F=33.0, R square = 0.58, p<O.OOl); Positive reinterpretation 2% (F=26.9, R square = 
0.60, p<0.02); Religion 3% (F=23.9, R square = 0.63, p<0.05). 
8.2.4 Depression as the dependent variable 
A two variable model accounted for most of the variance, with the variables entered in 
the following order: Venting emotions 24% (F=23.l, R square = 0.24, P<O.OOl); Alcohol 
6% (F=IS.5, R square = 0.30, p<0.05). 
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Therefore a significant proportion of the variance on all the outcome measures were 
predicted by use of certain coping strategies and hypothesis two can be confirmed. 
8.3 Correlations 
Hypothesis 3: There will be an association between age, psoriasis duration and gender 
and coping strategy. 
Table 5 shows that in this sample age is inversely related to subjective disability and 
psychological distress. A correlation matrix of the different coping strategies, age, and 
duration of psoriasis is presented in Table 6. In order to determine any influence of 
gender, Mann Whitney U tests were conducted. 
Table 6: Pearson correlation matrix: age, psoriasis duration and coping strategies 
Coping Strategy Age Psoriasis Duration 
Restraint -0.27* -0.058 
Positive Reinterpretation -0.24* 0.005 
Active coping -0.01 -0.01 
Planning -0.03 -0.15 
Emotional social support -0.185 -0.18 
Instrumental social support -0.091 -0.141 
Suppression of competing -0.236* -0248* 
activities 
Religion 0.052 0.063 
Acceptance 
-0.030 0.272* 
Mental disengagement 
-0.191 -0.200 
Venting emotions 
-0.360** -0.208 
Behavioural disengagement -0.275* 0.076 
Denial 
-0.230* 0.07 
Alcohol 
-0.286* 0.019 
Humour 
-0.338** 0.049 
* p < 0.05, **p < 0.01 
Gender differences were assessed conducting Mann Whitney U tests for male versus 
female on all the above variables. No significant differences emerged on the outcome 
measures. There was one significant difference with the use of coping strategies: women 
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scored significantly higher on the subscale of venting emotions than men (U=439, 
p<O.05). 
Psoriasis duration only correlated significantly with two coping strategies; suppression of 
competing activities and acceptance. There was a negative correlation with suppression 
of competing activities, suggesting that as people have psoriasis for longer, they are less 
likely to stop other activities in order to focus on the psoriasis. There was a positive 
correlation between acceptance and psoriasis duration, but not with age itself. 
Age was significantly inversely related to eight coping strategies: younger people 
showing more use of maladaptive coping strategies such as denial, disengagement, 
venting emotions and alcohol use. More use of positive reinterpretation, an adaptive 
strategy, however, also occurred in younger people. 
Therefore hypothesis three was confirmed: age was associated with greater use of coping 
strategies, and particularly with maladaptive strategies. Duration of psoriasis was 
associated with acceptance. Being female was associated with venting emotions - a 
maladaptive strategy. 
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8.4 Association between outcome measures and coping strategies. 
Hypothesis 4: Adaptive coping - acceptance, positive reinterpretation, planning, active 
coping - will be inversely related to scores on the four outcome measures. 
A series of Pearson's correlation coefficients were conducted to determine the 
relationship between the four outcome variables and use of different coping strategies. 
Table 7 gives the values of the correlation coefficients with significance indicated. 
Table 7: Pearson correlation matrix: outcome measures and coping strategies. 
Coping strategy Depression Anxiety PDI PLSI 
Restraint 0.259* 0.381** 0.246* 0.236* 
Positive 
-0.028 0.048 0.130 0.131 
reinterpretation 
Active coping 0.067 0.197 0.251* 0.232* 
Planning 0.023 0.183 0.208 0.136 
Emotional social 0.119 0.335* 0.161 0.118 
support 
Instrumental 0.147 0.299** 0.179 0.202 
social support 
Suppress other 0.272* 0.390** 0.358*· 0.339·· 
activities 
Religion 0.153 0.184 0.055 -0.029 
Acceptance 0.054 0.037 0.022 0.002 
Mental disengage 0.384** 0.554** 0.471** 0.463·* 
Venting emotions 0.501** 0.697** 0.601** 0.529·· 
Behavioural 0.374·· 0.384·· 0.318·· 0.340·* 
disengagement 
Denial 0.310** 0.251· 0.345** 0.270· 
Alcohol 0.330·· 0.173 0.317** 0.349** 
Humour 
-0.059 -0.055 0.013 -0.025 
• P <0.05,·* P < 0.01 
There were no significant correlations between acceptance, positive reinterpretation, or 
planning and any of the four outcome measures. Active coping was significantly 
positively related to subjective disability and psoriasis-specific stress, indicating that 
those who coped actively reported greater disability and distress as a result of psoriasis. 
Suppression of competing activities was also significantly associated with all four 
outcome measures. 
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Therefore the results do not confirm hypothesis four. 
Hypothesis 5: Maladaptive coping - behavioural disengagement, mental disengagement, 
denial, venting emotions, and alcohol/drug use - will be positively related to scores on 
the four outcome measures. 
Table 7 also gives the correlations of the maladaptive coping strategies and the outcome 
measures. All these coping strategies except alcohol/drug use were highly significantly 
correlated with all four measures of psychological distress and subjective disability. 
Alcohol/drug use was highly significantly correlated with all measures except anxiety. 
Therefore the coping strategies defined as maladaptive are related to elevated 
psychological distress in this sample and hypothesis five was confirmed. 
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9 STUDY 2 - PILOT INTERVENTION - DATA ANALYSIS 
9.1 Attendance 
Table 8 gives the attendance figures for the number of participants attending the groups, 
those who failed to attend, discontinuers, and the number of sessions that each attended. 
The total numbers of people completing the groups were six in the first group, four in the 
second group, six in the third group. There were 13 discontinuers: nine people had agreed 
to attend the first group, 10 people to groups two and three. 
Table 8 gives the numbers completing and discontinuing the three groups. 
Table 8: Numbers and percentages completing and discontinuing the three 
intervention groups 
Did not attend 1 to 3 sessions Completed Percentage 
N N N completing % 
Group 1 2 1 6 66.7 
Group 2 1 5 4 40 
Group 3 1 3 6 60 
Total 4 9 16 55 
Of those who completed the groups, the number of sessions attended ranged from five to 
seven. The total number of people attending each session varied between four and nine 
with the exception of session five in group two which had only two attenders. 
Reasons given for discontinuing included work or other evening commitments, difficulty 
with transport, or illness. In addition, one person felt that she had no need of the group, 
one person felt that he did not relate to the other group members, and one person found 
that hearing others' concerns made her feel more depressed. 
Therefore, in terms of the aim of the pilot intervention, it was shown to be possible to 
engage a sample of community psoriasis sufferers to attend an evening group. 
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9.2 Sample characteristics 
Table 9 gives the demographic data for whether in paid employment, marital status and 
whether currently receiving medical treatment for psoriasis. This included phototherapy, 
systemic therapy and topical treatment. 
Table 9: Numbers and percentages in intervention and control groups: paid 
employment, marital status and medical treatment for psoriasis. 
Paid work Not paid + partner single divorced widowed Current 
treatment 
Treatment 13 3 14 1 
-
1 13 
(81.2%) (18.8%) (87.5%) (6.3%) (6.3%) (81.2%) 
Control 9 7 10 3 2 1 15 
(56.2%) (43.8%) (62.5%) (18.8%) (12.5%) (6.3%) (93.7%) 
For both groups, more than halfwere in paid employment, and the majority were 
married or living with a partner. Eighty one percent of the treatment group and 93.7% of 
the control group were receiving medical treatment for their psoriasis at the time of the 
study. This covered a range from phototherapy and systemic treatment to topical 
treatment. 
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9.3 Match of treatment and control groups 
Table 10 gives the data for age, duration of psoriasis and gender for the treatment, control 
group and the discontinuers. Table 11 gives the initial scores on the four outcome 
variables for treatment, controls and discontinuers. In order to test whether the three 
groups differed significantly on these variables, a series of non parametric Kruskal 
Wallis tests were conducted. 
Table 10: Gender distribution, means and standard deviations for age and psoriasis 
duration in treatment group, controls and discontinuers. 
Treatment Control Discontinuers H p 
N= 16 N= 16 N= 13 
Age /yrs 47.4 (10.2) 50.5 (16.4) 49.4 (14.7) 0.79 NS 
Duration 24.0 (14.2) 28.0 (16.7) 26.3 (19.5) 0.20 NS 
psoriasis I yrs. 
Gender M 5 9 3 3.8 (Chi square) NS 
F 11 7 10 
There were no significant differences in the mean ages or psoriasis duration between the 
three groups. Gender distribution was tested using a chi square analysis. There were no 
significant differences in gender distribution. 
Table 11: Initial scores on outcome measures: means and standard deviations for 
treatment group, controls and discontinuers. 
Treatment Control Discontinuers Chi square p 
N= 16 N= 16 N= 13 
Subjective disability (PDI) 25.1 (20.8) 23.0 (24.5) 25.9 (19.0) 0.571 NS 
Psoriasis-stress (PLSI) 18.8 (11.2) 14.6 12.1) 17.7 (12.3) 1.871 NS 
Anxiety (HAD) 9.8 (5.9) 7.9 (4.8) 6.6 (6.0) 2.748 NS 
Depression (HAD) 7.8 (4.6) 7.1 (3.6) 7.1 (4.9) 0.735 NS 
There were no significant differences in the initial scores between the three groups. 
Therefore the treatment and control groups were reasonably matched, and the 
dis continuers did not differ significantly on initial scores from those who completed the 
groups. 
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9.4 Outcome of group intervention 
In order to evaluate the changes in outcome variables due to the intervention, a series of 
repeated measures ANOV As were conducted using the outcome variables and coping 
strategies. 
Hypothesis 6: Treatment participants will show a significantly greater reduction in 
scores on the four outcome measures than controls. 
Table 12 gives the mean scores before and after the intervention for the treatment and 
control groups on the four outcome measures. The F value stated in the table gives the 
value for the group * time interaction effect. Degrees of freedom for the F statistic were 
all1,30. Individual changes in scores are given in Appendix 9. 
Table 12: Outcome measures: means, standard deviations and significance before 
and after the intervention for treatment and control groups 
Treatment Control F p 
pre post pre post 
Subjectivedisab (PDI) 25.1 (20.8) 16.1 (17.5) 23.0 (24.5) 21.3 (21.5) 2.9 0.09 
Psoriasis-stress (PLSI) 18.8 11.2) 15.8 (9.7) 14.6 (12.1) 16.1 (21.2) 1.5 NS 
Anxiety (HAD) 9.8 (5.9) 8.7 (4.4) 7.9 (4.8) 8.4 (4.0) 1.1 NS 
Depression (HAD) 7.8 ( 4.6) 7.3 (4.4) 7.1 (3.6) 8.1 (4.1) 1.3 NS 
• P <0.05 
There were no significant group * time interaction effects for any of the outcome 
measures, although there was a trend for a greater reduction in subjective disability (PDI) 
in the treatment than in the control group. 
As the ANOV As assume normal distribution, non parametric within-group and between 
group analyses using the Wilcoxon Signed Ranks test and Mann Whitney U test 
respectively were also employed as a precaution. For the within-group analyses there was 
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one significant result - a significant reduction in subjective disability from pre to post 
intervention in the treatment group (Z=-2.5, p=O.Ol). There were no significant between-
group differences on any post intervention outcome measures. 
Figures 1 to 4 give the mean scores in the treatment and control groups before and after 
the intervention. Although no significant group*time interaction effects were found, the 
figures show that change was in the direction of score decrease solely in the treatment 
group on all four measures. 
15 
13 
11 
Score 
Fig 1: Anxiety 
-+-Treat 
-·-Control 
; 1..========-5+-1----.. 
pre post 
Fig 3: Depression 
15 -+-Treat 
13 -·-Control 
11 
Score 
9 
7. • 
5 I 
pre post 
Fig 2: Subjective Disability 
4°L 30 
Scor~O .--=--_~ __ _ 
':1+-_____ ~ 
-+-Treat 
-.-Control 
Pre Post 
Fig 4: Psoriasis Stress 
~i 
-+-Treat ScoriO 
I!' -.-Control • 
1: j 
Pre Post 
No significant reduction in treatment relative to control group occurred on any of the four 
outcome measures, therefore hypothesis six is not confirmed. 
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Hypothesis 7: Treatment participants will show a significantly greater increase in 
adaptive coping strategies than controls. 
Table 13 gives the means and standard deviations of scores on the 15 coping subscales 
for the treatment and controls before and after intervention. F gives the value of the 
group*time interaction effect. One repeat coping questionnaire in the control group had 
only been partially completed and was excluded from this analysis, leaving N=15 in the 
control group. Degrees of freedom for the F statistic were all 1,29. 
Table 13: Coping strategies: means, standard deviations and significance before and 
after intervention for the treatment and control groups 
Treatment Control 
COPE pre post pre post F p 
Restraint 9.3 (3.1) 9.6 (3.4) 7.3 (2.9) 6.5 (1.9) 1.6 NS 
Positive 10.2 (2.9) 10.7 (2.9) 7.5 (3.2) 7.5 (2.9) 0.4 NS 
reinterp 
Active 11.1 (3.5) 11.3 (3.0) 9.2 (3.2) 9.1 (2.9) 0.0 NS 
Plan 11.4 (3.2) 12.1 (3.4) 7.6 (3.0) 7.7 (3.0) 0.4 NS 
Emotional 9.2 (2.9) 9.6 (3.5) 8.1 (2.8) 7.5 (2.7) 2.1 NS 
support 
Instrumental 9.4 (3.6) 9.8 (3.7) 7.6 (2.7) 8.3 (3.0) 0.1 NS 
support 
Suppress 9.2 (3.5) 9.5 (2.3) 7.1 (3.0) 7.2 (2.7) 0.1 NS 
other acts 
Religion 5.3 (2.1) 6.4 (3.6) 6.1 (3.8) 6.2 (3.7) 1.2 NS 
Accept 11.7 (3.6) 11.9 (2.5) 11.3 (3.5) 9.6 (2.9) 1.728 NS 
Mental 8.3 (2.3) 8.1 (2.2) 6.8 (3.3) 8.3 (3.3) 4.2 0.05 • 
disengage 
Vent 9.7 (3.7) 9.7 (3.5) 7.3 (3.6) 7.6 (3.2) 0.005 NS 
emotions 
Behave. 6.8 (3.4) 7.1 (2.6) 6.6 (3.2) 6.5 (3.0) 0.3 NS 
disengage 
Denial 5.9 (2.5) 6.8 (3.0) 5.7 (2.0) 6.1 (3.3) 0.2 NS 
Alcohol 4.1 (0.3) 4.1 (0.3) 4.8 (1.6) 5.8 (3.1) 4.3 0.05 • 
Humour 5.9 (2.1) 7.9 (3.0) 6.4 (2.1) 6.4 (1.9) 6.2 0.05 • 
• p < 0.05 df=l, error df=29 
There were no significant group * time interaction effects for any of the adaptive coping 
strategies, although there was a slight trend for an increase in the seeking of emotional 
social support in the treatment group. There was a significant group * time interaction 
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effect at the p< 0.05 level for use of mental disengagement, alcohol and humour. It can 
be seen that scores on mental disengagement and use of alcohol! drugs stayed similar in 
the treatment group pre and post intervention, and showed an increase in the control 
group over the study time period. There was an increase in the use of humour in the 
treatment group over the period of the study. 
As many of the scores on the adaptive coping methods were already high pre treatment, 
there may have been a ceiling effect on the results. 
Therefore treatment participants did not show a significantly greater increase in adaptive 
coping strategies relative to controls and hypothesis seven was not confirmed. 
9.5 Participant evaluation 
Hypothesis 8: participants will evaluate the groups positively in terms of perceived 
usefulness, relevance and enhancement of coping ability. 
Table 14 gives the mean ratings of the participants on the feedback questionnaire which 
was constructed using a five point scale from 0 to 5. 
Table 14: Feedback ratings 
Min Max Mean 
Usefulness 2 5 4.25 (1.00) 
Relevance 3 5 4.13 (0.89) 
Group context 4 5 4.56 (0.51) 
Effect on ability to cope 2 5 3.56 (1.03) 
Most participants rated the group highly in terms of its usefulness, relevance to concerns, 
group context (enabling members to express their concerns), and effects on ability to 
cope. The highest rated was the ability to express concerns in the group context, the 
lowest rated was the effect on perceived ability to cope, although this was still rated 
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highly by all but two of the participants. The same participant rated the groups low for 
usefulness and for effect on ability to cope. 
In order to determine the match between participant evaluation of group and the objective 
measures, the above four questions from the feedback form were correlated with the 
change in scores on the standardised measures. Difference was calculated by subtracting 
the initial scores from the post intervention scores so that a positive outcome score 
indicates a drop in psychological distress. These differences were then intercorrelated 
with the measures of participant rating, using non parametric correlations. 
Table 15: Correlation matrix: participant ratings with change in outcome measures 
Usefulness Relevance to Group context Increase in 
concerns ability to cope 
Subjective 0.04 0.13 0.15 0.05 
disability change 
Psoriasis-stress 0.21 0.21 0.07 0.18 
change 
Anxiety change 0.18 0.09 0.27 0.42· 
Depression 0.01 -0.06 0.08 0.13 
change 
• P <0.05 
There was one significant correlation: increase in perceived ability to cope correlated 
significantly with decrease in anxiety. 
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9.6 Individual change. 
While clinically significant change was not assessed in this study, the numbers of 
participants above and below clinical cut off for anxiety, depression and psoriasis specific 
stress were considered in the treatment and control groups, in case the intervention was 
differentially effective with those whose scores are above the clinical cut off initially. 
Using cut off score of greater than or equal to 10 on the anxiety and depression measures 
(indicating probable depression and anxiety), and greater than or equal to 10 on the 
measure of psoriasis specific stress, Table 16 gives the numbers and percentages: 
Table 16: Clinical cut off scores: numbers and percentages in treatment and control 
groups for anxiety, depression and psoriasis-specific stress 
Anxiety Depression Psoriasis-stress 
Pre Post Pre Post Pre Post 
N % N % N % N % N % N % 
Treatment 8 50 7 43.8 6 37.5 5 31.3 13 81.3 11 68.8 
Control 5 31.3 5 31.3 5 31.3 7 43.8 9 56.3 7 43.8 
Therefore in the treatment group the number of people above clinical cut off decreased on 
all three measures over the treatment period. In the control group, the number of people 
above clinical cut off stayed constant on the measure of anxiety ,increased on the 
measure of depression, and decreased for psoriasis specific stress. 
64 
9.7 Individual comments by group participants 
Other qualitative questions on the form asked "as a result of the group, do you intend to 
use any new or different coping strategies, if so, what?" "what did you find most 
helpful?", "what did you find least helpful ?", and a space for any other comments. 
Fig 5 Fig 6 
New or different coping strategy What did you find most helpful 
100 
100 80 
80 • sharing 
• techniques 60 
60 0/0 • coping 
0/0 • relationships 40 C understand 40 Cmood 20 
20 0 
0 
% = percentage of participants making comments which related to that category. Figures 
do not add to 100% as some participants made more than one comment. 
Figures 5 and 6 above give the percentage of comments grouped into three themes for 
each question. Answers to use of a new or different coping strategy were grouped into 
three categories. Specific coping techniques were mentioned by six people, such as 
"writing things down that concern me", "dealing with each small thing at a time", 
"challenging negative automatic thoughts". The relationships category, referred to by 
four people, consisted of comments relating to assertiveness, confidence or being an 
equal: "try not to spend too much time worrying what others think", "try to think of 
myself as an equal". The third category, mood, was referred to by five people: "take a 
more positive approach", "try not to enter vicious circles so much". Six people left this 
question blank. 
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Answers to the question "what did you find most helpful" were grouped into the three 
categories of sharing concerns with others, learning coping strategies and increased 
understanding of thoughts and feelings. In the first category, mentioned by 14 people, 
were comments such as "realising that I am not the only one". The second category, 
which five people referred to, consisted of comments such as "learning coping 
techniques", "how to cope in different ways", "evaluate the situation in order to prevent 
negative thoughts from overtaking". In the third category, four people mentioned greater 
understanding of their own and others' thoughts and feelings - "stopping to think about 
people's reactions to psoriasis and my reactions to them". 
The question about what was least helpful was left blank by four people (25%), while 
four people stated that it had all been helpful (25%). Three people (18.8%) mentioned 
the group process, including the lack of commitment from group members who had 
discontinued, or the lack of understanding of certain group members (these three were all 
members of the same group). One person mentioned the travelling, one person the little 
headway with medical treatments, one the lack of a social collective approach to psoriasis 
and one person wished the meetings had been longer. 
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IV DISCUSSION 
The discussion will begin with a section summarising the results, then consider 
methodological problems in sections 2 and 3. Section 4 will interpret the results in terms 
of the application of the coping framework to psoriasis and sections 5 and 6 will review 
clinical and research implications. 
10.1 Summary of results 
This two pronged investigation into chronic psoriasis and coping aimed to consider the 
role of coping strategies in mediating the influence of psoriasis on subj ective disability 
and psychological distress, and to explore the efficacy of a group based intervention 
using a Coping Effectiveness Training format. 
10.1.1 Overall sample characteristics 
The overall initial response rate of 45% was similar to 49% reported in an investigation 
of psoriasis sufferers recruited from dermatology clinics (Finlay & Coles, 1995) which 
is lower than figures of 60% to 71 % typically reported for community surveys from 
G.P. practices (Koo, 1996; O'Neill & Kelly, 1996). Gender distribution, duration of 
psoriasis and proportion of participants who were in paid employment were similar to 
previous investigations. The mean age of 49.7 years was slightly higher than means of 
35 years (Ramsay & O'Reagan, 1988) to 46 years (Koo, 1996) reported in the literature, 
skewed by a high proportion of respondents in their late 60's. In terms of psychological 
distress, the figures demonstrated that this sample of people with psoriasis were 
exhibiting elevated depression and anxiety (27%) and worry due to psoriasis (62%), 
figures consistent with the research (McHenry & Doherty, 1992; McKenna & Stem, 
1997). 
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10.1.2 Study one results 
The fIrst study investigated the coping strategies mediating the impact of psoriasis on 
subjective disability and psychological distress. Subjective disability was best 
accounted for by the measure of anticipatory-avoidance behaviour as found by Fortune 
et al (1997b), rather than by the variables of age, duration of psoriasis, gender, anxiety 
and depression. Beliefs in, or experience of, others' negative evaluations only added a 
small (3%) independent contribution to the variance predicted by behaviour; venting 
emotions was the variable best accounting for the remaining variance (7%). When the 
reciprocal relationship between the outcome variables themselves was removed, coping 
strategies of venting emotions, mental disengagement and alcohol use accounted for a 
signifIcant proportion of the variance on measures of psychological distress and 
subjective disability with venting emotions accounting for between 24% and 48% of the 
variance and being the strongest coping predictor, appearing in all regression models. 
These coping strategies were found to be more important than age, gender and psoriasis 
duration in accounting for psychological outcome and, along with denial and 
behavioural disengagement, correlated positively with psychological distress, fIndings 
which are consistent with research into coping strategies in spinal cord injury (Kennedy 
et al in press). In addition, age was signifIcantly negatively correlated with maladaptive 
coping strategies and psychological distress. There were no signifIcant gender 
differences on measures of distress or subjective disability, but the coping strategy of 
venting emotions was positively associated with female gender. Adaptive coping 
strategies were generally high in the sample as as whole. Apart from a small 
contribution (in the positive direction) from positive reinterpretation in predicting 
anxiety, adaptive coping strategies did not appear in the regression models. In contrast 
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to previous findings in chronic health conditions, active coping was significantly 
positively related to subjective disability and to psoriasis specific stress. 
10.1.3 Study two results 
The second study, the pilot intervention, indicated that it was possible to engage 
psoriasis sufferers in a series of evening groups based on the format of Coping 
Effectiveness Training. Twenty nine people out of the overall sample of89 agreed to 
attend the groups (33%) and of these, 16 people completed, a rate of 55%. These 
attendance rates were positive given the reported difficulties with engaging psoriasis 
sufferers in group based psychological interventions, with uptake in past studies found 
to be as low as 10% (Fortune et ai, 1998). Structured coping groups have also been 
found to have higher drop-out rates than non directive, supportive groups, possibly due 
to the greater commitment required of participants (Schwartz, 1999). In terms of 
perceived usefulness, the group intervention yielded positive individual feedback which 
mentioned use of specific coping techniques learnt during the groups. Increase in 
perceived ability to cope as a result of the group correlated significantly with reductions 
in the measure of anxiety. However there were no significant group*time interaction 
effects on outcome variables or on use of adaptive coping strategies, although there was 
a trend for a decrease in SUbjective disability in the intervention relative to the control 
group. 
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10.2 Methodological Limitations: study one 
10.2.1 Sample 
The sample was recruited from two different sources simultaneously; the hospital 
dermatology clinic and the psoriasis selfhelp group, introducing possible extraneous 
variables. Although initial scores on the questionnaire measures were not significantly 
different between these two sources there may have been other systematic differences 
between the sources such as differences in psoriasis severity, which were not measured 
by this study. According to previous research, the proportion of people with psoriasis in 
the community seeing a dermatologist was approximately 15% (Ramsay & O'Reagan, 
1988), and the proportion of sufferers recruited through G.P. practices who are members 
of the psoriasis association was approximately 3% (O'Neill & Kelly, 1996). The study 
thus represented a subset (those who responded) of two subsets of psoriasis patients (the 
hospital outpatient clinic and the psoriasis association). Recruiting from the psoriasis 
association may have introduced systematic bias to the sample as those who had decided 
to join the association were arguably people who utilised social support and active 
coping to a greater extent than non-members. Overall, the relative dearth of respondents 
from the younger age bracket of sufferers could be due to bias in the sources from which 
sufferers were recruited, local geographical bias in age distribution of psoriasis, or may 
suggest that older people were more likely to respond to the study. It is a possibility 
that younger people were less likely to respond, and a speculation could be that perhaps 
self consciousness and feelings of stigmatisation were more salient in the younger age 
group, as found in the research (Gupta & Gupta, 1995b) which may have inhibited 
involvement in the study. 
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10.2.2 Measures 
No measure was taken of psoriasis severity: previous research has shown poor 
correlations between objective and subjective measures of severity (Root & Kent, 1994) 
and this study aimed to look at the effect of the intervention on people's perceived 
disability in daily life due to the condition. The measures used may not have been 
representative of peoples' condition throughout the time period of data collection due to 
the fluctuating nature of psoriasis and changes in treatment. 
10.2.3 Implementation and evaluation 
The cross sectional design did not enable a causal link to be investigated between 
maladaptive coping strategies and the outcome measures. It would have been useful to 
conduct a follow up to ascertain the nature of these relationships and the extent of their 
stability over time. 
10.3 Methodological limitations: study two 
10.3.1 Sample 
Participants were not excluded from the pilot intervention on the basis of comorbid 
medical or psychological difficulties with the exception of those receiving ongoing 
psychological treatment (one person). The sample participating in the intervention were 
self selected and allocation to treatment or control group was not randomised. While 
these factors were prohibitive in terms of investigating pure treatment effects 
(Chambless & Hollon, 1998), they did allow clinical effectiveness - the real life 
application of the intervention - to be ascertained. Clinical effectiveness may be poorly 
related to the results from pure research trials (Berger, 1996). 
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10.3.2 Measures 
Although questionnaires were obtained within a month of commencing the intervention 
groups, there may still have been considerable change in scores on the measures used 
within this time. Psoriasis exhibited seasonal variation for many sufferers, and the 
groups were conducted from a time period spanning October to April. The sample sizes 
in the pilot intervention were too small to permit comparisons between the three 
intervention groups and it may have been that these three groups differed significantly 
from each other. The first intervention group was mainly composed of the hospital 
outpatients, while the second and third groups were mainly composed of members of 
the psoriasis association. 
The measures used may not have detected change along all relevant dimensions. Self 
efficacy has been postulated as a mechanism through which change may occur 
following Coping Effectiveness Training (King & Kennedy, 1999) which was supported 
anecdotally by group participants who referred to increased self confidence following 
the groups. A measure of self efficacy may have yielded useful information. There was 
no measure of self concept which, with hindsight following group discussions, may also 
have been informative to ascertain. Difficulties with the COPE measurement will be 
discussed further in following sections. 
10.3.3 Implementation and evaluation 
In the pilot study the three intervention groups were each different in composition and 
character, which made them all interesting and informative to run but also introduced 
biases in that they could not be conducted identically, even though the same 
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framework was used. The groups were conducted by the researcher alone, with no 
external checks on constancy of group material and it was likely that the learning 
experience of conducting the groups led to their slight modification over time. This 
study differed from Coping Effectiveness groups conducted with inpatient samples who 
were in the same environment while the groups are in progress, and largely isolated 
from outside events. In the psoriasis groups, many of the individuals were also in the 
midst of various life events or daily stresses which at times, took precedence over 
psoriasis in the discussions, but always with a focus, such as coping with multiple 
demands, problem solving, vicious cycles. In some cases psoriasis onset was believed to 
have been precipitated by a major life event such as a bereavement. This demonstrated 
how psoriasis interacted with and amplified other life stresses and the impossibility of 
disconnecting psoriasis from these events. 
A follow up may have yielded interesting results: it is increasingly recognised that 
psychological interventions may continue to have beneficial effects after their cessation, 
particularly if emphasising acquisition of new, stable skills (Chambless & Hollon, 
1998). 
10.4 Application of coping theory and intervention to psoriasis 
The condition of psoriasis differs in many significant ways from other groups to which 
theories of appraisal and coping, and Coping Effectiveness Training, have been applied. 
It is not life threatening, the population is more heterogeneous than for spinal cord 
injury (predominantly young adults, more male than female), or the HIV studies which 
have been restricted to homosexual men. In addition, the condition itself varies widely 
not merely across individuals but fluctuates within individuals, from intense, 
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debilitating relapses to periods of remission. Psoriasis may also be distinguished by its 
degree of chronicity: it often appears at puberty or in early adulthood and so may 
become inextricably linked with development of social identity and self concept due to 
its visibility and associations with stigma. 
The average duration of psoriasis in the sample was over 20 years so most individuals 
had very established ways of coping and were familiar with psoriasis and its difficulties. 
In contrast, Coping Effectiveness Training in spinal injury was introduced as part of the 
rehabilitation during the early weeks I months post injury, while Coping Effectiveness 
Training in HIV was linked to the post diagnosis phase - in itself marking a discrete 
event. Educative coping groups encouraging the contemplation of new, adaptive 
strategies and to reduce the fear of an overwhelming event would seem to be timely at 
this point. In the case of psoriasis, coping needed to be conceptualised in the context of 
established ways of living with the chronic condition. 
Within the context of these differences, it was interesting to examine the findings. 
10.4.1 Study one: Coping strategies 
The findings of study one contributed to the increasing body of research on the role of 
adaptive and maladaptive coping in chronic health conditions and provided new 
information on the coping strategies influencing subjective disability and psychological 
distress in psoriasis. When considering the influence of coping and demographic 
variables on each outcome measure, the empirically defined maladaptive strategy of 
venting emotions accounted for the largest proportion of the variance, (between 24% to 
48%) on measures of anxiety, depression, psoriasis specific stress and subjective 
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disability - appearing as a consistent factor in all regression models. While expressing 
emotions is believed to be healthy and is linked to acceptance of the losses inherent in a 
chronic condition, venting emotions refers to persistent emotional preoccupation with 
negative or unbearable aspects of a condition. Venting emotions may directly influence 
mood and may also occupy attentional resources, reducing capacity for other, more 
adaptive strategies. There are aspects of psoriasis which may predispose sufferers to 
experiencing intense emotions: as well as the lack of known cause, poor controllability 
and unpredictable course of the condition which may give a sense of battling with an 
invasive force (Jobling, 1992), there is social experience of rejection, perceived lack of 
public awareness or interest in the condition, lack of role models of individuals with 
psoriasis, and stigmatisation. These are ingredients which have been identified in the 
general literature and linked to feelings of humiliation, shame and guilt as well as anger 
towards treatment by others (Gilbert, 1997). A questionnaire assessment revealed that 
46% of outpatients reported moderate or severe anger during psoriasis flares (Fried et ai, 
1995). Anger has also been conceptualised in chronic illness as part of a response to 
loss (Ogden 1996, Ch.13), and may also be present due to ongoing rejection and 
victimisation in the sufferer's life (Lewis, 1998). The strong association found in this 
study between venting emotions and subjective disability and distress thus has 
important implications for how the condition is viewed and dealt with by the individuals 
with psoriasis themselves, and the influence of their families and society. 
While the maladaptive strategies previously identified in other medical conditions were 
also shown to be influential in psoriasis, the predicted relationship with adaptive 
strategies was not found in this study: there were no significant negative associations 
between adaptive coping strategies and psychological impact and one significant 
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positive association between active coping and subjective disability and psoriasis-
specific stress. In general, the sample were exhibiting high levels of adaptive coping, 
consistent with research showing that people with psoriasis are well adjusted socially 
(Dooley & Finlay, 1989). The lack of association between adaptive coping and positive 
outcome may be due to difficulties in measurement of adaptive coping, which will be 
discussed further, but there may also be important differences in the coping of those 
who suffer from psoriasis as opposed to other conditions. Often psoriasis can be 
concealed, especially in the winter, and people may go to great lengths not to be 
identified as having the condition. So a constant striving not to draw attention to 
psoriasis and not to appear inadequate may utilise strategies defined as adaptive, such as 
active coping and planning, but which may nevertheless be a source of anxiety and 
distress, initiated in attempts to compensate for the condition. There is some evidence 
that in experimental studies people with psoriasis demonstrated good interpersonal 
adjustment yet reported high levels of anxiety (Weinstein, 1984). Interestingly, in 
contrast to the findings in other chronic health conditions, acceptance did not correlate 
with any measures of psychological outcome. Self reported acceptance has previously 
been documented in the literature as important in adjusting to life with psoriasis (Kang 
Seng, 1997) but acceptance in the context of psoriasis may take a different meaning. In 
conditions such as cancer and HIV there may be acceptance for the progressive and 
potentially terminal implications of the diagnosis. In the case of psoriasis, acceptance 
may rather be linked to acceptance of identifying oneself as someone with psoriasis and 
accepting oneself - a meaning which may not be picked up by the COPE measurement. 
A positive sense of self may be central to the ability to live with the condition and is 
linked to the concept of shame - a belief in aspects of oneself as inherently flawed and a 
subsequent devaluing of oneself and status relative to others (Gilbert, 1997). In this way 
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the role of psoriasis in individuals' experience of themselves, both in the present and in a 
developmental context, may have directly influenced psychological well-being. 
10.4.2 Study One: Demographic factors in coping 
The finding that age was significantly inversely correlated with all outcome variables 
except depression was consistent with the literature suggesting that psoriasis has greater 
psychological impact on younger people (Gupta & Gupta, 1995b). Duration of psoriasis 
was significantly inversely correlated with anxiety and subjective disability suggesting a 
lessening of psychological distress over the duration of the condition. Similarly duration 
of psoriasis, but not age itself, was significantly correlated with acceptance, suggesting a 
specific illness-adjustment process (although as noted above, acceptance itself was not 
correlated with psychological well-being). In terms of coping, this study found a 
significant inverse relationship between age and use of maladaptive strategies. It may 
have been that greater use of maladaptive strategies in younger people predicted greater 
levels of distress. As this was a cross sectional study direction of causality could not be 
predicted, but it is known that maladaptive strategies in themselves are likely to be 
associated with psychological distress. In terms of social and occupational functioning, 
the literature has suggested that psoriasis may have greater impact on young people who 
are establishing relationships, rather than in an existing, established network (Koo, 
1996). Social avoidance and disengagement may then act to further isolate young 
individuals and increase their distress. Use of alcohol in order to cope was also 
significantly inversely associated with age and has been linked to rejection and 
stigmatisation (Ginsburg, 1995). However, use of humour and positive reinterpretation, 
adaptive strategies, were also inversely associated with age, which may suggest that 
younger people also employ a greater variety of coping strategies, or are more aware of 
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doing so. In the context of the importance of venting emotions as a predictor of 
psychological distress, it was interesting that females were more likely to utilise this 
coping strategy. However, the overall scores on outcome measures did not differ 
significantly between males and females. The greater use of venting emotions among 
the women in the sample may have been related to demographic factors such as 
occupational status. In a working environment there may be more distractions from the 
condition, venting emotions may be more inhibited and self esteem may be increased. It 
would have been interesting to determine if these gender differences still existed in a 
sample matched for occupation. The literature on gender differences in the impact of 
psoriasis is mixed (O'Neill & Kelly, 1996), suggesting the interaction of many factors 
are involved. 
10.4.3 Study two: Coping Effectiveness Training for psoriasis 
Study two was successful in engaging a community sample of psoriasis sufferers to 
participate in evening groups using the format of Coping Effectiveness Training: three 
evening groups were run, each of seven sessions. Between nine and ten people were 
invited to the groups which was the maximum for the room capacity and similar to the 
size of other groups run with psoriasis sufferers (Price et ai, 1991). The 55% completing 
the groups is lower than that reported for other CET groups (Chesney & Folkman, 1996; 
King & Kennedy, 1999), but comparable to groups for a community sample of psoriasis 
sufferers who have been found to be difficult to recruit, considering that the group 
sessions spanned a seven week period and were utilising a structured problem focused 
format, which has been associated with better outcome but higher drop out rates than 
non directive support (Schwartz, 1999). 
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For some participants, attendance necessitated a considerable drive on dark evenings, 
and demonstrated that there was perceived need for, and willingness to attend, such 
groups. Feedback, and group discussions, made it clear that there was a sense of 
isolation among sufferers in the community in coping with the impact of the condition. 
Factors which enhanced the engagement seemed to be the interest and support of both 
the medical staff at the dermatology clinic and the psoriasis association. An emphasis on 
the practical, problem solving focus of the groups and on the difficulties of living with 
psoriasis seemed to evoke the interest and support of sufferers. 
The other aims of the group were to ascertain whether a Coping Effectiveness Training 
group would reduce psychological distress and subjective disability, and enhance 
adaptive coping. 
While there were no significant changes on any of the outcome measures relative to the 
control group, there was a trend for a relative decrease in subjective disability in the 
treatment group. Within-group analyses yielded a significant reduction in subjective 
disability in the treatment group post intervention. Significant findings from within 
group analyses in the absence of group*time interaction effects have been documented 
in stress management groups for people with atopic dermatitis (Neibe11991, cited in 
Ehlers et aI, 1995). Several reasons for lack of significant findings in this study could 
be postulated: that the groups were not useful in achieving their aims, that the changes 
were not being measured by the instruments used, that the changes were not measurable 
in such a small sample. Participants feedback was largely positive showing that the 
groups were perceived to be useful. In addition, individual feedback made specific 
reference to use of appraisal and coping techniques. The importance of enhanced 
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understanding of self perceptions and perceptions of others, through considering 
automatic thoughts and assumptions, was also highlighted. Comments such as "when 
ones emotions are running high and the negative thoughts kick in I found it most helpful 
to learn how to deal with this: to evaluate the situation in order to prevent the negative 
thoughts overtaking and evolving into a vicious cycle"; "I will deal with each small 
problem and not let them build up and get out of control": demonstrated that not only 
were the groups serving a supportive function, but were enhancing people's awareness 
of the role of the coping strategies they employed in moderating their thoughts and 
mood. The ratings of perceived increase in ability to cope as a result of the group 
intervention correlated significantly with decrease in anxiety over the intervention 
period, suggesting measurable change associated with perceived enhancement of coping 
ability. Individual change in scores (Appendix 9) showed that some participants did 
seem to benefit on the outcome measures. There were a few negative comments which 
related to difficulties due to group members who discontinued, highlighting the 
importance of a stable group environment, and the disruption of people not being able to 
attend on certain nights, or discontinuing; difficult to avoid for practical reasons with a 
community sample. Closer matching of participants may have reduced discontinuers: 
group two had the highest rate of discontinuers and this sample seemed to be the most 
disparate one in terms of views of psoriasis and concerns. There may be both 
advantages and disadvantages to such mixed groups: people may feel that the groups do 
not provide a setting where they can speak freely and be understood. Conversely, such 
settings may provide opportunities for mutual influence, and diversity of coping 
strategies may fuel change to a greater extent than a forum where concerns and ways of 
coping are very similar (Schwartz, 1999). Differences across the age range was a theme 
discussed at length in the third group, which spanned from 26 years to 65 years. Some 
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younger members became determined to be less concerned about the view of others and 
to resume discarded activities. One woman returned to a group meeting and announced 
that she had been swimming during the previous week, inspired by the discussion that 
had taken place. The group therefore showed the potential benefits of a range of ages 
and experiences. 
In terms of the aim of enhancing adaptive coping, there were no significant increases in 
adaptive coping strategies, although interestingly, most participants commented not just 
on an increased ability to cope, but made reference to specific techniques discussed, 
such as "I shall try to be more assertive with the help of the 'Six assertiveness skills 
sheet'" ; "I shall concentrate on writing things down that concern me". One possible 
explanation is that there was a ceiling effect - the initial scores on adaptive coping 
strategies as measured using the COPE were already high. The COPE may be a poor 
measure of change, and may be measuring dispositional, rather than situational coping, 
which would tend to retain stability over time (Kennedy et al in press). Another 
possibility raised earlier in the discussion is that those strategies empirically defined as 
adaptive were actually linked, in psoriasis, to people striving hard to compensate for 
perceived inadequacies and therefore were also linked to experience of stress and 
anxiety. Consistent with the literature on stigma in people who have psoriasis, group 
discussions provided some evidence of an intense feeling of self disgust in some 
individuals who were themselves repulsed by psoriasis and their own appearance. It 
emerged that people often pushed themselves to work hard and to be valued along other 
dimensions in order to counterbalance the feared negative impact of their appearance 
and own underlying sense ofinadequacy. Shame was found to be a useful concept to 
discuss in the groups, and related to individual's current experiences of rejection as well 
81 
I ' 
, ' 
as when young, for example being bullied at school as a result of psoriasis. Anger was 
also a central focus of people's experience of living with psoriasis, and was reported to 
interfere detrimentally with emotional well-being. 
10.5 Clinical implications 
Several implications can be drawn from the two studies constituting this investigation. 
The results have highlighted the elevated levels of psychological distress which exist in 
the popUlation of people with psoriasis, and has provided some evidence that 
maladaptive coping strategies, particularly the venting of emotions, significantly predict 
subjective disability and psychological distress in this population. 
These findings support the development of structured interventions to target coping 
strategies, with the aim of reducing subjective disability and ameliorating distress. 
Judging from the sense of isolation expressed by sufferers, it would seem to be 
important to incorporate structured groups into a medical framework of care, offering a 
holistic approach to the condition and recognising its psychological impact. The 
education of medical professionals with regard to the psychological aspects of psoriasis 
and ways of coping with the condition would seem to be important. There may be a 
role for training other professionals or lay people in conducting structured self help 
coping groups, as has been successfully undertaken in the psychological management of 
rheumatoid arthritis (Lorig, Gonzalez, Laurent, Morgan, Laris, 1998). 
The results of study two, the pilot intervention, indicated that the psoriasis population 
showed an interest in problem focused groups and that from subjective evaluation the 
Coping Effectiveness Framework was an appropriate one relevant to the needs of this 
population. While the standard measures did not yield significant differences relative to 
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the control group there were sufficient indications of beneficial effects from the group 
intervention to warrant further study. 
Engagement in this study was believed to be enhanced by the support of the medical 
profession and the psoriasis association and demonstrated the importance of integrating 
the intervention with existing care so that the link between medical care and coping with 
the condition is endorsed as part of an approach to dealing with psoriasis which 
maximises quality of life. The nurses at the ward where the groups were run had 
expressed an interest in establishing groups in the future and there are plans for the 
group format to be discussed with the medical team. 
It was interesting to observe that, out of the three intervention groups conducted, 
individuals in the first group composed mainly of a subset of sufferers recruited through 
the hospital dermatology clinic seemed to benefit to a greater extent on outcome 
measures than those recruited through the psoriasis association. The pattern of change 
can be observed from the individual score changes for each participant (Appendix 9). 
While the sample was too small to permit between-group analysis of the three 
intervention groups, it may have been that there were certain subgroups of sufferers 
more likely to benefit from a structured coping focused intervention, as has been 
suggested in Multiple Sclerosis (Schwartz, 1999). Targeted interventions, if subgroups 
were identified accurately, would be likely to be cost effective. From the current study 
it can only be speculated why there may have been a differential response to the 
intervention between hospital clinic and self help subgroups. Possibilities include that 
the hospital recruits were suffering from more severe psoriasis or were receiving less 
pre-existing social support, or exhibited more commitment to the intervention. If it 
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could be established that certain groups were most at risk, or most likely to benefit from 
Coping Effectiveness Training, interventions could be moulded to the needs of these 
groups. One subgroup suggested by the current study as potentially benefiting from a 
structured coping group was the younger age group of sufferers. Comments from 
participants who attended the groups suggested that they would have particularly valued 
a version of Coping Effective Training when they were young: "It would have been 
most helpful for me to be involved in a coping group in my early 20's"; "I just wish 
something like this could have been formed some time ago ... it was so nice to think that 
at last it is being looked at by people without the problem". 
The adaptation and modification of the Coping Effectiveness Training format would 
follow from increased research and knowledge of coping with psoriasis. 
10.6 Research implications 
The information in study one highlighted the need for more research into the utilisation 
of coping strategies in this population, in particular to further investigate the role of 
adaptive coping strategies in psoriasis, and to develop measurements of coping that are 
sensitive to change. It would be interesting to conduct longitudinal research to identify 
whether maladaptive coping strategies have a predictive role in psychological distress, 
and the extent to which such coping is stable or fluctuates with change in the condition. 
The chronic nature of psoriasis provides a different context in which to in investigate 
coping - in particular, whether a distinction can be made between dispositional and 
situational coping. The COPE only measures the presence or absence of certain 
strategies, may not be sensitive to change, and does not inform us as to the salience of 
the strategies. For example, people may indicate that they plan, but the quality or 
effectiveness of the planning is not known. There is a need for more direct measures of 
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coping, such as through use of diaries and semi-structured interviews (Coyne & Gotlieb, 
1996). 
This discussion has suggested that stable negative self concept may predispose to 
shame, and hence psychological distress, even in the presence of adaptive coping. The 
emotional state of shame occurs when internal global negative attributions are made 
from events, leading to characterlogical rather than behavioural self-blame (Lewis 
1998). Shame prone individuals may cope adaptively with psoriasis, but attribute 
failings or difficulties to flaws in themselves, whereas those experiencing rejection but 
with relatively high self concept may attribute rejection specifically to psoriasis, with 
less detrimental effect on overall self perception. Longitudinal research in psoriasis has 
provided some evidence for the existence of stable negative self concept in patients 
regardless of the current state of their skin (McKenna & Stem, 1997). Schwartz (1999) 
conducted directive problem focused groups with people who had multiple sclerosis and 
found that self blame and blaming of others both decreased in the intervention group -
evidence that these can be addressed in a time limited, structured intervention. Recent 
research has demonstrated the direct influence of illness beliefs on subjective disability 
which were not mediated by coping response (Scharloo et aI, 1998). Illness beliefs 
include beliefs in perceived cause, consequences, controllability, duration and identity 
and therefore denote the meaning of the illness to the individual. 
Therefore not only do sensitive measures of coping strategies need to be developed but 
further understanding of the complex interaction between illness beliefs, shame, coping 
strategies, subjective disability and psychological distress, would seem to be a useful 
focus for future research. 
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V: CONCLUSIONS 
The main findings from these two studies were: 
1) Detailed analysis of the coping strategies used by psoriasis sufferers revealed that 
venting emotions and disengagement emerged as consistent predictors of subjective 
disability and psychological distress, being more important than age, gender and 
duration of psoriasis. 
2) A community sample of sufferers were engaged to attend an intervention based on 
Coping Effectiveness Training and perceived this to be useful. Although there were no 
significant changes in the treatment relative to control group on outcome measures or 
adaptive coping, there was a trend towards relative reduction in subjective disability in 
the treatment group. Perceived increase in ability to cope due to the group was also 
found to correlate significantly with measured decrease in anxiety. 
The pilot study demonstrated that evening groups in the format of Coping Effectiveness 
Training could be implemented for psoriasis sufferers in the community: the focus of 
the groups was valued by participants and perceived to lead to acquisition of coping 
skills. 
It was suggested that there were enough interesting trends in the data and enough 
interest from participants to warrant further study and systematic evaluation of the use 
of CET in this popUlation. It was suggested that developments and modifications in the 
CET format should ensue from further research into the detailed use of coping strategies 
in the population of people with psoriasis. A further suggestion was made that particular 
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subgroups may benefit differentially from the groups, such as those requiring outpatient 
treatment, and younger people, with particular attention required to engagement factors. 
It was hoped that in the future some form of coping programme, which has the 
advantage of being structured and focused, may be integrated into the medical care 
regime and accessible to more people with psoriais, particularly at the time of 
identification of the condition. 
Implications for further research were highlighted as the need for further investigation 
into the processes involved in use of coping strategies, and their stability over time, in 
this population. In particular, the need to investigate the dynamic relationship between 
coping strategies, illness beliefs and identity, self concept and shame was emphasised, 
which will require improvements in direct measures of problem solving, and measures 
sensitive to change. 
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Letter introducing the study 
-{Name} 
{Address} 
{Address} 
{Address} 
{address} 
I. Dear --________ _ 
, 
I am a trainee clinical psychologist working with Dr. Susan Burge, Consultant 
Dermatologist, and Dr. Paul Kennedy, Consultant Clinical Psychologist. We 
are planning to carry out a study to increase our understanding of how to help 
people cope with living with psoriasis. 
Research has shown that people with psoriasis experience a variety of feelings 
and concerns. Wh~tever your experience of psoriasis, we are interested in 
finding out how psoriasis affects your daily life and whether a new technique, 
called Coping Effectiveness Training, helps people with psoriasis to cope more 
effectively with their condition. 
We would be grateful if you were willing to assist us with this research. 
Please would you complete the enclosed slip, and return it in the prepaid 
envelope, to indicate whether or not you would be interested in finding out 
more about the research and in discussing the possibility of taking part. Your 
. decision will in no way affect any present or future medical care for your 
condition. 
Yours sincerely 
Laura Hill 
Trainee Clinical Psychologist. 
Tel: 01865226431 
APPENDIX 3 
Letter to participants, information sheet and consent form 
(Tel: Isis Education Centre 01865226431) 
{Name} 
{Address I} 
{Address 2} 
{Address 3} 
{Address 4} 
Dear ----------, 
Study into Psoriasis and Coping 
Thank you for expressing your interest in the above study. 
23/11/98 
Further to our telephone conversation in October, I am enclosing an information 
sheet about the study, the questionnaires, and a consent form. 
I would be grateful if you could complete the questionnaires and consent form, and 
return them to me in the prepaid envelope. As you will see, there are four 
questionnaires. It should take about 15 minutes to complete all four. I would like to 
emphasise that all responses will be treated as strictly confidential and that the results 
will only be used for statistical analysis. 
If you expressed interest in the group programme, I will contact you shortly after I 
receive the questionnaires. 
If you were not interested in the group programme, or if you will no longer be able to 
attend a group, it would still be very helpful to receive your questionnaire responses, 
as this will increase our understanding of the experience of living with psoriasis. 
Best wishes, 
Yours sincerely, 
Laura Hill 
Trainee Clinical Psychologist 
Oxford 
Radcliffe 
!:S!-.H:C?:;~::~(r(A2,t~%~·l~; Isis Education Centre. Tel: 10865 226431 
Mn IJ 
DERMATOLOGY 
INFORMATION SHEET DERMATOLOGY DEPARTMENT 
Old Road 
Research in several physical conditions and illnesses have demonstrated that 
building on existing ways of coping can help people to live with, and adjust to, 
some of the difficulties which.arise from their condition This technique, called 
Coping Effectiveness Training, has not yet been developed for people with 
Headington 
Oxford 
OX37LJ 
psoriasis but, alongside existing treatments, may help to reduce the distress which .. 
Enqumes' 01865-228232 psoriasis can cause. This study plans to increase our understanding of how to APpoinm:ents: 01865-228206 
develop ways of coping for people who have psoriasis. Cinical FAX: 01865-228240 
Ward 01865-228250 
I would be grateful if you would consider taking part in this study. If you agree to 
take part, it would involve initially completing some questionnaires and rating 
scales to give us more information about the ways in which psoriasis is affecting 
your life, and how you deal with these difficulties. 
If you are interested in attending the group programme, I will ask you to come to a 
group which would meet one evening weekly, for about an hour, for seven weeks, 
The meetings would take place at the Churchill Hospital and would be led by 
myself. and attended by other people with psoriasis who have agreed to take part 
in this study (a maximum of9). The content of each meeting would be given at 
the start, and the focus would be on ways of coping. It is hoped that the groups 
would be interesting and enjoyable as well as useful. 
Participation in the study is entirely voluntary and you may decide to withdraw 
from the study at any point. Your decision whether or not to take part will not 
influence any treatment that you are receiving, or may in the future receive. Any 
information obtained during the study will be treated as strictly confidential and 
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APPENDIX 4 
Demographic question sheet 
Please would you answer the following questions. 
Age: 
Sex: male / female 
Marital status: 
(please circle) 
occupation: 
Psoriasis duration: 
(please circle) 
single married 
Age at onset of "psoriasis: 
divorced widowed 
Medical treatment currently receiving for psoriasis: 
APPENDIX 5 
Standard measures 
Psoriasis Disability Index 
Psoriasis Life Stress Inventory 
COPE scale 
Hospital Anxiety and Depression Scale 
PSORIASIS DISABIYTY INDEX 
Thank you for your help in completing this questionnaire. Please could 
you note the following points. 
1. Every question relates to the LAST FOUR WEEKS ONLY. 
2. Every question should be answered by ringing one of the 
numbers from 0 - 6. "0" represents "Not at all" and "6" 
represents "Very much". The other numbers represent 
grades between these two extremes. 
3. There are two different versions of question 6, 7 and 8. 
If you are at regular work or at school please answer the 
first batch of questions 6 - 8. If you are not at work or school 
please answer the alternative questions on page 2. 
4. Please note that there are 15 questions. Please check that you have 
answered all the guestions on the three pages. 
psORIASIS DISABILITY INDEX 
All questions relate to the LAST FOUR WEEKS. 
DAILY ACTIVITIES: 
1. How much has your psoriasis interfered with you carrying 
out work around the house or garden? 
Not at all = o 1 2 3 4 5 
2. How often have you worn different types or colours of 
clothes because of your psoriasis? 
Not at all = o 1 2 3 4 5 
6 = Very much 
6 = Very much 
3. How much more have you had to change or-wash :your clothes? 
Not at all = o 1 2 3 4 5 
4. How much of a problem has your psoriasis been at the 
hairdressers? 
Not at all = o 1 2 3 4 5 
6 = Very much 
6 = Very much 
5. How much has your psoriasis resulted in you having to take 
more baths than usual? 
Not at all = o 1 2 3 4 5 6 = Very much 
Continued next page 
........ • ... t .. _~"'" 
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All questions relate to the LAST FOUR WEEKS. 
WORK OR SCHOOL (if appropriate) 
6. How much has your psoriasis made you lose time off work or 
school over the last four weeks? 
Not at all = o 1 2 3 4 5 6 = Very much 
7. How much has your psoriasis prevented you from doing things 
at work or school over the last four weeks? 
Not at all = o 1 2 3 4 5 6 = Very much 
8. Has you career been affected by your psoriasis? e.g. 
promotion refused, lost ajob, asked to change ajob. 
Not at all = o 1 2 3 4 5 6 = Very much 
IF NOT AT WORK OR SCHOOL: ALTERNATIVE QUESTIONS 
6. How much has your psoriasis stopped you carrying out your 
normal daily activities over the last four weeks? 
Not at all = o 1 2 3 4 5 6 = Very much 
7. How much has your psoriasis altered the way in which you 
carty out your normal daily activities over the last four 
weeks? 
Not at all = 0 1 2 3 4 5 6 = 
8. Has your career been affected by your psoriasis? e.g. 
promotion refused, lost ajob, asked to change ajob. 
Not at all = 0 1 2 3 4 5 6 = 
Very much 
Very much 
Continued next page 
- 3-
All questions relate to the LAST FOUR WEEKS. 
PERSONAL RELATIONSHIPS: 
9. Has your psoriasis resulted in sexual difficulties over the last four weeks? 
Not at all = o 1 2 3 4 5 6 = Very much 
10. Has your psoriasis created problems with your partner or any of your 
close friends or relatives? 
Not at all = o 1 2 3 4 5 6 - Very much 
LEISURE: 
11. How much has your psoriasis stopped you going out socially 
or to any special functions? 
Not at all = o 1 2 3 4 5 6 = Very much 
12. Is your psoriasis making it difficult for you to do any sport? 
Not at all = o 1 2 3 4 5 6 = Very much 
13. Have you been unable to use, criticised or stopped from 
using communal bathing or changing facilities? 
Not at all = o 1 2 3 4 5 6 = Very much 
14. Has your psoriasis resulted in you smoking or drinking 
alcohol more than you would do normally? 
Not at all = o 1 2 3 4 5 6 = Very much 
TREATMENT: 
15. To what extent has your psoriasis or treatment made your 
home messy or untidy? 
Not at all = o 1 2 3 4 5 6 = Very much 
Thank you for your help. 
CAY Finlay 1993. This must not be copied without the permission of the author. 
Pleas~ respond to ALL statements 
·:\:::::·.t:·:::·:;·::;.:.:· :: .. : .... -:::. ': .:. :,. . ' ..... :: .. :::.::: .. : ......... : .. ' .. '.:: .:::'.:':::.::':::':': :::.::: .. : .... ·:N.ot .... ;.:$.~J;m'.~::; 
. , .......... :. .'. ..' . . .' ., . . . .:'.. .... at all : d~J!.(cc .' 
N.(~e~~~C. .' .. :.::.'. A·#a!,~~.: .. :.':. 
dc~;Cf.(.' .. ::.; . ileaL:. :' .: . 
1. Inconvenienced by t~e shedding of your skin 
2. Feeling self-conscious among strangers 
3. Feeling that you have to set aside a large part 
of your time to take care of your psoriasis 
• ,~) ", I • 
4. Not going to public places (e.g.,. swimming 
baths, health club; restaurant) when you would 
have liked to 
s. Wearing unattractive or uncomfortable clothes 
in. order to cover. ~~a:tain regions of your body 
, <,' ~ '. .,. • 
6. Having to avoid sunbathing in the company of 
others 
7. Fear of having serious side-effects from 
medical treatment 
8. People treating you as if your skin condition is 
contagious 
9. Avoiding social situations 
to. Strangers (children or adults) making rude or 
insensitive remarks about your appearance 
11. Not enough money to pay medical bills 
12. Feeling like an "outcast" or "social misfit" a 
great deal of the time 
13. People making a conscious effort not to touch 
you 
14. Hair.dresser appearing reluctant to cut your 
hair 
IS. People implying that your skin condition may 
be due to AIDS, Leprosy, or a Venereal disease 
I Response choices: 
1. I USUALLY DON'T DO THIS AT ALL 
2. I USUALLY DO THIS A LITTLE BIT 
3. I USUALLY DO THIS A MEDIUM AMOUNT 
4. I USUALLY DO THIS A LOT 
1 2 3 4 
! 
1. I try to grow as a person as a result of the experience. 
2. I turn to work or other substitute activities to take my 
I mind off things. 
3. I get upset and let my emotions out. .. 
I 
! 
4. I try to get advice from someone about what to do. 
! 
5. I concentrate my efforts on doing something about it. 
6. I say to myself "this isn't real". 
! 7. I put my trust in God. 
8. I laugh about the situation. 
9. I admit to myself that I can't deal with it, and give up trying. 
10. I restrain myself from doing anything too quickly. 
11. I discuss my feelings with someone. 
12. I use alcohol or drugs to make myself feel better 
{or would like to}. 
13. I get used to the idea that it happened. 
14. I talk to someone to find out more about the situation. , 
15. I keep myself from getting distracted by other 
thoughts or activities. 
16. I daydream about things other than this. 
17. I get upset, and am really aware of it. 
18. I seek God's help. 
I 
1 2 3 4 
'19. I make a plan of action. 
120. I m.ake jokes about it. 
121. I accept that this has happened and that it can't be changed. 
1
22
. 
I hold off doing anything about it until the situation permits. 
1
23
. 
I try to get emotional support from friends or relatives. 
24. I just give up trying to reach my goal. 
I 
25. I take additional action to try to get rid of the problem. 
I 
26. I try to lose myself for a while by drinking alcohol or 
I taking drugs (or would like to). .. 
27. I refuse to believe that it has happened. 
28. I let my feelings out. 
!29. I try to see it in a different light, to make it 
seem more positive. 
1
30. I talk to someone who could do something concrete 
about the problem. 
31. I sleep more than usual. 
32. I try to come up with a strategy about what to do. 
33. I focus on dealing with this problem, and if necessary 
let other things slide a little. 
34. I get sympathy and understanding from someone. 
35. I drink alcohol or take drugs in order to think about it less 
(or would like to). 
36. I kid around about it. 
37. I give up the attempt to get what I want. 
38. I I.ook for something good in what is happening. 
39. I think about how I might best handle the problem. 
40. I pretend that it hasn't really happened. 
41. I make sure not to make matters worse by acting too soon. 
I 1 2 3 4 
42. I try hard to prevent other things from interfering with my 
I efforts at dealing with this. 
43. I watch TV to think about it less. 
! 44. I accept the reality of the fact that it happened. 
45. I ask people who have had similar experiences what they did. 
I 
46. I feel a lot of emotional distress and I find myself expressing 
those feelings a lot. 
147. I take direct action to get around the problem. 
48. I try to find comfort in my religion. 
I 
49. I force myself to wait for the right time to do something. 
1
50
. 
I make fun of the situation. 
51. I reduce the amount of effort I'm putting into solving 
I 
the problem. 
52. I talk to someone about how I feel. 
1
53
. 
I use alcohol or drugs to help me get through it (or would like 
to). 
54. I learn to live with it. 
55. I put aside other activities in order to concentrate on this. 
56. I think hard about what steps to take. 
57. I act as though it hasn't even happened. 
58. I do what has to be done, one step at a time. 
59. I learn something from the experience. 
60. I pray more than usual. 
~ 
Please indicate how you are feeling now, 
or how YOll have been feeling in the last 
day or two by ticking the column to the ( , 
right of each of the following 
statements: 
1 I wake early and then sleep badly for 
the rest of the night. 
2 I get very frightened or have panic 
feelings for apparently no reason at all. 
3 II feel miserable and sad. 
4 I feel anxious when I go out of the 
house on my own. 
5 I have lost interest in things. 
6 I get palpitations, or a sensation of 
'butterflies' in my stomach or chest. 
7 I have a good appetite. 
6 I feel scared or frightened. 
9 I feel life is not worth living. 
10 I still enjoy the things I used to. 
11 I am restless and can't keep still. 
12 I am more irritable than usual. 
13 I feel as if I have slowed down. 
14 Worrying thoughts constantly go 
through my mind. 
Yes Yes No, not No, not 
definitely sometimes much at all 
APPENDIX 6 
Letter to control group 
{Name} 
{Address I} 
{Address 2} 
{Address 3} 
{Address 4} 
Dear .-------
Psoriasis and coping 
You may remember that you filled in some questionnaires a few months ago, asking 
about the day to day difficulties that living with psoriasis may cause, and how you deal 
with them. At the time I asked if you would be willing to complete the same 
questionnaires later on, to help us understand how things naturally change over time. 
I hope that you are still willing to do this. 
I enclose a further set of the questionnaires and would be very grateful if you could 
take the time to complete them and return them in the prepaid envelope. These are the 
same questionnaires which you completed previously. It does not matter if your 
responses this time are not the same as before - it is important to answer according to 
how things are for you now, or during the last four weeks. 
As you stated that you were unable to attend a group programme, I will not be asking 
you to participate further in the study. However, if you would like to receive a brief 
summary of the findings once the study is completed, please write a note on the 
questionnaires when you return them, and I will send this to you. The study should be 
finished by summer 1999. 
Thank you for your help with this study. 
Best wishes, 
Yours sincerely, 
Laura Hill 
Trainee Clinical Psychologist 
APPENDIX 7 
Participants feedback sheet 
Psoriasis and coping group 
It would be very helpful to have your views on how useful you have found the group. 
Please would you answer the questions below, by circling the number on the rating 
scale, and add any other comments that you wish overleaf. 
1) How useful did you find the group? 
o 
not useful 
1 . 2 3 4 5 
very useful 
. 2) What did you find the most helpful? 
3) What did you find the least helpful? 
4) Did you feel your concerns were addressed? 
o 
not at all 
1 2 3 4 5 
very much so 
5) Did you feel able to express your concerns in this context? 
o 
not at all 
1 2 3 4 5 
very much so 
6) As a result of the group, do you feel more able to cope with your concerns? 
o 
not at aU 
1 2 3 4 5 
much more able 
7) As a result of the group, do you intend to use any new or different coping 
strategies? If so, what? 
Please add any other comments overleaf. 
APPENDIX 8 
Summary of intervention content 
SUMMARY OF INTERVENTION CONTENT 
Session one covers the aims of the group, introductions, and guidelines. Stress, and 
people's understanding of it, is raised. The relationship between stress and psoriasis 
is then discussed in pairs and ways in which psoriasis adds to stress in life, both due to 
particular events and external situations, and due to internal thoughts and worries. 
Lists of the external sources of stress in psoriasis and internal fears and concerns 
which contribute to stress are generated. Examples are given of the ways in which 
situations can be viewed as stressful due to both external factors and internal factors. 
This leads to a discussion of stress, appraisal and coping. People are asked to 
consider their own personal signs and reactions to stress during the week, and how 
these affect their lives. 
Session two: people's individual reactions to stress are discussed and the theory of 
stress, appraisal and coping is reviewed. The process of appraisal of situations is 
outlined: defining the problem, breaking the problem down into small parts through 
use of who, what, where and when questions. This is practised as a group exercise 
through examples volunteered by individuals. The consideration of changeable versus 
unchangeable aspects to stressful situations, and to psoriasis, is emphasised. Adaptive 
coping - a good match between situation and coping strategy - is defined. People's 
changing reactions to psoriasis over time are examined to consider the role of coping, 
and the link of appraisal and coping. Acceptance for unchangeable aspects - the 
incurable nature of psoriasis - is discussed, as well as dealing with the intermittent 
nature of psoriasis. Attention is drawn to the role of avoidance as a way of coping 
with feared situations. People are asked to assess the changeability of stressful 
situations that evolve during the week, or a past situation which they would have liked 
to have handled differently, and to consider anything that is now avoided due to fear. 
Session three outlines a six step model of problem solving. Problem scenarios are 
then passed around group members as an exercise with the group, using the 
application of the problem solving approach. Some typical scenarios used are: 
- A relative keeps questioning you about your treatment, telling you of new remedies 
that you should try. 
- You go to the swimming pool. After getting changed and walking into the pool area, 
you are asked to leave by a pool attendant. 
- When your psoriasis is at its worst, your partner seems afraid to touch you. 
- You are in a cafe with a relative and are hot. You take your jacket off. Your relative 
gets embarrassed and asks you to put it back on. 
- You are at ajob interview and become aware of scales falling off your skin. 
Session four considers emotional reactions to having psoriasis, and outlines the link 
between thoughts, feelings and behaviour. The vicious cycle of panic is used as an 
example, and fuels an exercise on social anxiety, thoughts, feelings and physical 
changes in anxiety inducing situations. The impact of avoidance on thoughts, feelings 
and behaviour is discussed in the group, and the role of psoriasis in anxiety and 
avoidance. Self esteem and its link with low mood and withdrawal is outlined. A list 
of activities which help elevate self esteem and enable people to 
relax is generated by participants, and this is contrasted with unhelpful reactions and 
activities, such as turning to alcohol. Relaxation tapes are issued to participants. 
Session five: the negative assumptions which underpin typical negative automatic 
thoughts are focused on with an emphasis on how automatic thoughts may be 
deceptive and may lead to a sense of disempowerment in situations. Typical 
assumptions behind some thoughts identified in psoriasis are generated such as " if 
people knew the real me they would reject me". Shame is discussed and the role of 
early experiences ofrejection. An example of identifying negative automatic thoughts 
and challenging them is given by the scenario of an acquaintance walking past 
without saying hello or smiling, and discussion generated about possible negative 
automatic thoughts. People then discuss in pairs situations and try to identify the 
automatic thoughts, and are asked to try to "catch" negative automatic thoughts during 
the week. 
Session six: reviews the group content so far and allows time for discussion of the 
material raised. Differences between group members in their dealing with psoriasis, 
such as the role of age and gender in influencing the way in which situations are 
interpreted, and the coping strategies employed, are used to explore the ideas covered. 
and the importance of flexible, adaptive coping. Within individuals, changes in 
appraisal of psoriasis over time, and the interaction of other events in life, are 
considered. Life goals are discussed, and the importance of matching goals to realistic 
appraisal of what is attainable. The role of psoriasis in shaping life goals, and any 
positive value that can be gleaned from the experience of living with psoriasis, are 
reviewed. 
Session seven is devoted to social support and social interactions. The importance of 
social support, and valuable sources of it, is discussed in the group. The difficulties 
posed by psoriasis are used to highlight assertive, passive and aggressive styles of 
interaction. People discuss a social situation they have been in lately that they found 
difficult, and how they would have liked to deal with it differently, and then one 
which they felt they handled well. The group ends by discussing any points that 
people feel has not been covered by other sessions, and what people would have liked 
to see included in a future group. 
APPENDIX 9 
Individual change in scores on outcome measures 
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